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 “Ubiquitous” is probably the most appropriate term to introduce the intestinal 
protozoan parasite Giardia duodenalis, which is a primary cause of diarrhea. 
 
First of all, this protozoan does not show a distribution that is limited to a certain 
area, country or even continent: Giardia can be found in hosts all over the globe, both in 
temperate regions and in parts of the world with a more tropical climate. Secondly, G. 
duodenalis as a species shows no strict host specificity and can infect humans as well as a 
wide range of animals varying from pets to wild life. Finally, in most of these different 
host species the prevalence numbers collected for Giardia can be fairly high (Feng and 
Xiao, 2011). This is explained further on in chapter 1, where prevalence numbers are 
listed.  
 
The latter especially applies to cattle. Finding a G. duodenalis free herd is, to say the 
least, challenging and finding an uninfected calf in a farm where Giardia is present is 
basically impossible.  In addition, giardiosis in cattle is characterised by the chronicity of 
the infection, which translates in faecal cyst excretion for a long duration of time as 
shown in more detail further on in chapter 1. When a Giardia infection in ruminants 
results in clinical disease, the most common symptom is diarrhea. It is now suspected that 
Giardia has an impact on production in these animals, as was already shown in goat kids 
and lambs. In cattle, no conclusive data are available on this topic (Geurden et al., 2010), 
but Giardia is considered as a primary cause of ill thrift and diarrhea and thus could 
potentially lead to significant losses in production.  
 
This introductory chapter will summarize the current knowledge on this intestinal 
parasite with a particular focus on the pathogenicity, clinical signs and host immune 
responses observed in different host species.   
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1.1. Nomenclature and taxonomy of Giardia 
 
Over the years, the nomenclature of the intestinal parasite we now know as Giardia 
has been a subject of controversy and change. The first description of a protozoon 
resembling Giardia dates back to 1681 and was done by the Dutch microscopist Antonie 
Van Leeuwenhoek whilst examining his own stool (Figure 1.1.) (Dobell, 1920). In 1859, 
Vilem Lambl “rediscovered” Giardia and called it Cercomonas intestinalis, unaware that 
this name was already reserved for another organism. The final genus name Giardia was 
chosen in tribute to a Belgian taxonomist, Alfred Mathieu Giard and first used in 1882 
(Boreham et al., 1990). Although this genus name is now well established, the species 
name lamblia is still used interchangeably with intestinalis and duodenalis in literature. 
In this thesis, G. duodenalis will be used for purposes of consistency.  
 
 
   
 
 
 
 
 
 
   
                   
                  
           Figure 1.1:  The first drawing of Giardia by Van Leeuwenhoek 
 
 
In 1952, after years of host specificity as inspiration for the species name, Filice 
introduced three major species with a nomenclature based on morphology of the median 
body, an unique microtubule structure that is important in the formation of the main 
attachment organelle named the ventral disc. This resulted in the following species: (1) 
the amphibian species G. agilis; (2) the rodent species G. muris and (3) the human 
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species G. duodenalis, although organisms of this last group have also been described in 
other mammals, birds and reptiles.  Currently, G. ardea (birds), G. microti (muskrats and 
voles) and G. psittaci (birds) are accepted as additional species, bringing the total to 6 
species (Plutzer et al., 2010).   
Further research on G. duodenalis using molecular tools revealed that this species 
is in fact a species complex consisting of eight assemblages (A to H). Some of these 
assemblages are host-specific while others infect a (limited) range of hosts (Feng and 
Xiao, 2011). More recently, attempts have been made to re-use species names based on 
host occurrence (Thompson and Monis, 2004), such as G. canis for assemblages C and D 
found in dogs and G. bovis for assemblage E found in lifestock. However, this still 
remains a suggestion and awaits acceptance by the research community. The established 
Giardia species and G. duodenalis subspecies are summarized in table 1.1. 
Regarding taxonomy, there are two ways to classify Giardia. An old system based 
on morphology would assign Giardia to the Phylum Sarcomastigophora, Subphylum 
mastigophora (=Flagellata), Class zoomastigophorea, Order Diplomonadida and Family 
Hexamitidae (Morrison et al., 2007). However, based on new genetic, structural and 
biochemical data Giardia belongs to the Phylum Metamonada, Subphylum Trichozoa, 
Superclass Eopharyngia, Class Trepomonadea, Subclass Diplozoa, Order Giardiia and 
Family Giardidae (Cavalier-Smith, 2003). 
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Table 1.1. Giardia species and G. duodenalis assemblages 
Species  Assemblage Host range Reference  
G. agilis  Amphibians Kunstler, 1883 (Adam, 
2001) 
G. ardeae  Birds Noller, 1920 (Adam, 2001) 
G. microti  Muskrats and voles (Feely, 1988) 
G. muris  Rodents Grassi, 1879 (Adam, 2001) 
G. psittaci  Birds (Erlandsen and Bemrick, 
1987) 
G. 
duodenalis 
Assemblage A 
(=G. duodenalis 
sensu stricto?)* 
Humans, nonhuman primates, 
ruminants, alpacas, pigs, horses, 
canines, cats, ferrets, rodents, 
marsupials, other mammals 
(Karanis and Ey, 1998) 
 Assemblage B 
(=G. enterica?) * 
Humans, nonhuman primates, 
cattle, dogs, horses, rabbits, 
beavers, muskrats 
(Homan et al., 1992) 
 Assemblage C 
(= G. canis?) * 
Domestic and wild canines (Meloni and Thompson, 
1987; Monis et al., 1998) 
 Assemblage D 
(= G. canis?) * 
Domestic and wild canines (Monis et al., 1998) 
 Assemblage E 
(= G. bovis?) * 
Domestic ruminants, pigs (Ey et al., 1997) 
 Assemblage F 
(=G. cati?) * 
Cats (Monis et al., 1999) 
 Assemblage G 
(=G. simondi?)* 
Mice, rats (Monis et al., 1999) 
 Assemblage H Marine mammals (Lasek-Nesselquist et al., 
2010) 
* Proposed species names, not yet accepted 
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1.2. Life cycle of Giardia 
 
To complete its simple direct life cycle (Figure 1.2.), Giardia appears in two forms: 
the flagellated trophozoite and the infective cyst stage, both efficiently adapted to 
survival in different environments (Svard et al., 2003). After cyst ingestion by the host, a 
trophozoite needs to be liberated in the intestinal lumen through a process called 
excystation. The initiating signal of this process is the presence of H+ ions in gastric 
secretions (Bingham et al., 1979), but emergence of the trophozoite in this environment 
would destroy it. Further triggers to finalize the excystation, such as exposure to 
proteases and nutrients, are present in the small intestine (Gillin et al., 1989).  
Once released in the intestinal lumen, the parasite rapidly divides and colonizes the 
intestine with a preference for the jejunum. At this point, trophozoites appear as pear-
shaped organisms with two nuclei, four pairs of flagella and a ventral disc. The flagella 
permit the parasite to move through the fluids in the intestine, while the ventral disc gives 
it the ability to attach to the intestinal wall (Adam, 2001).  
Since trophozoites are unable to survive outside of the intestinal lumen, completion 
of the life cycle and transmission to the next host requires the formation of cysts through 
a process called encystation. High concentrations of bile salts, fatty acids and a slightly 
alkaline pH have been identified through in vitro studies as possible triggers of this 
process (Gillin et al., 1988). During encystation, proteins are produced internally and 
secreted to form the important cyst wall while a severe remodeling of the cytoskeleton 
takes place to internalize the flagella and the ventral disc (Elmendorf et al., 2003; Palm et 
al., 2005). The end product is a rounded cyst with four nuclei that has no mechanism to 
attach to the intestine and will be shed in the faecal material.  
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Fig 1.2. Life cycle of Giardia.  
The life cycle of Giardia commences by ingestion of infectious cysts by the host (1). 
Once the small intestine is reached, excystation takes place and trophozoites are liberated 
(2). Trophozoites divide by binary fission (3) and colonize the small intestine (4). High 
concentrations of bile salts, fatty acids and a slightly alkaline pH may trigger a 
trophozoite to form a cyst (encystation) (5). The cysts and to a lesser extent trophozoites 
are excreted via the faeces (6). Only the cysts survive in the environment and are 
immediately infectious upon excretion and ready for transmission to the next host.  
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Giardia possesses certain key characteristics that greatly influence its epidemiology 
and transmission. A first important element is the immediate infectiveness of cysts. As 
soon as excretion occurs, they are ready to be ingested and to successfully infect a new 
host. In addition, only a low number of cysts is needed to establish infection: a dose as 
little as 10-100 cysts already proved to be sufficient in human experiments (Rendtorff, 
1954; Thompson and Monis, 2004). The combination of the low infection dose with the 
large numbers of cysts excreted in the faeces explains the rapid spreading of Giardia 
between hosts. In ruminants, cyst excretions as high as 106 cysts per gram faeces were 
found (O'Handley and Olson, 2006) indicating that infection pressure can increase 
immensely in a very short period of time. 
Giardia cysts remain infectious for months upon excretion depending on the 
environmental matrix and the surrounding temperature. A few examples are the survival 
of Giardia cysts in water of 12 weeks, 6 weeks in hard soil (Olson et al., 2004), 18 days 
in human faeces (Deng and Cliver, 1992) and 7 days in cattle slurry (Olson et al., 1999; 
Grit et al., 2012). All in all, the resistance in the environment ensures a steady build up of 
the environmental contamination.  
 
1.3.  Prevalence of Giardia duodenalis 
 
 
Occurring throughout tropical and temperate regions worldwide, G. duodenalis can 
be considered as the most commonly found intestinal pathogenic protozoon in humans, 
with an estimated 280 million new infections every year (Lane and Lloyd, 2002). In the 
industrialized world, prevalence rates vary from 2 to 7% (Fletcher et al., 2012) and 
infections are often associated with international mobility (Ekdahl and Andersson, 2005). 
This was shown in a study on travel- and migration-associated illnesses, where Giardia 
was revealed as the most common parasitological cause of gastro-intestinal complaints 
(Field et al., 2010). In developing countries, prevalence rates vary from 20 to 30% and 
infections are linked to poor sanitary conditions, overcrowding and poor water quality 
(Younas et al., 2008). Human infections are associated with G. duodenalis assemblage A 
and B, with different studies giving a varying distribution of these assemblages, 
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sometimes even within a country. Worldwide, assemblage B seems to be slightly more 
common than assemblage A (Feng and Xiao, 2011). 
The presence of G. duodenalis is however not limited to humans. A broad range of 
animals, including both companion and farm animals, are often infected with host 
specific and/or in several cases zoonotic Giardia assemblages. Prevalence rates in cats 
and dogs range from <1 to 45% in sheltered dogs (Upjohn et al., 2010) and 4 to 11% in 
cats (Olson et al., 2010). The host-specific assemblages C and D are the most regularly 
discovered assemblages in dogs, although assemblage A was also found at fairly high 
rates. In cats, both assemblage A and F can cause infection, with a more frequent 
occurrence of assemblage F (Feng and Xiao, 2011). Regarding production animals, 
worldwide prevalence data are especially available for ruminants and pigs. A study in 
Denmark on pigs showed a prevalence rate of 17.3% (Maddox-Hyttel et al., 2006), while 
an Australian study found a prevalence of 31.1% (Armson et al., 2009), predominantly of 
assemblage E and to a lesser extent also A (Feng and Xiao, 2011).  In sheep and goats, 
infection rates vary from 1.5% to 55.6% and 12.3 to 42.2% respectively. These animals 
are mostly infected with assemblages E and A (Feng and Xiao, 2011). In cattle, 
prevalence rates range from 9 to 73% on an animal level, with the highest prevalence 
found in 1 to 6 month old animals. Looking at prevalence numbers on a farm level, 
percentages of 45% to 100% are mentioned in literature (Geurden et al., 2008). On a 
positive farm, the cumulative incidence is 100%, i.e. every animal will get infected on 
that farm once Giardia is present in one of them (Geurden et al., 2010). When looking at 
the genetic data, the livestock specific assemblage E is the dominating genotype in cattle 
in Europe, Australia and North America. However, in these areas assemblage A has been 
found as well, making it the most common zoonotic genotype. Only a small percentage of 
cattle have tested positive for assemblage B. New-Zealand appears to have a different 
distribution of assemblages compared to other areas of the world. Here, assemblage A 
and B are most common, whereas assemblage E is nearly absent in calves (Feng and 
Xiao, 2011).  
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1.4.  Zoonotic potential of G. duodenalis 
 
As described above, animals can harbor the same assemblages as those occurring 
in humans, thus hinting a zoonotic potential for G. duodenalis. In addition, infectivity 
studies with cysts isolated from both animals and humans have shown that zoonotic 
transmission is indeed possible (Monis and Thompson, 2003). On the other hand, when 
looking at the frequencies at which these zoonotic assemblages appear, they seem to be 
outcompeted by the host-specific assemblages E, C, D and F of the different production 
and companion animals.     
Only a few epidemiological studies have examined the real zoonotic risk of 
Giardia infections in animals. Work done in New Zealand and the United Kingdom did 
not identify contact with pets or exposure to dogs or cats as a risk factor for Giardia 
infections in humans. An increased infection risk was however found for people working 
closely with farm animals such as farmers (Hoque et al., 2002; Hoque et al., 2003; Stuart 
et al., 2003).  
Assemblage A is the most commonly appearing zoonotic assemblage in different 
animal species and has thus raised the most interest. This assemblage has been divided in 
sub-assemblages AI, AII and AIII, with humans being mostly infected by AII and 
animals with AI (Feng and Xiao, 2011). Although still not occurring often, the same 
subgroups are from time to time found in animals and humans. In a study done on cattle 
(Geurden et al., 2008), the same subgroup AII was detected in calves as was earlier 
described in humans. It should be noted that finding the same genotypes in humans as in 
animals does not warrant zoonotic transmission. Only dynamic epidemiological studies 
on humans and animals living in close proximity (such as the same household) could give 
conclusive information on the zoonotic potential of G. duodenalis. 
 
1.5. Clinical signs and pathology  
 
After its discovery, Giardia raised questions and debate regarding its pathogenic 
potential. Interestingly, its discoverer Van Leeuwenhoek did already make an association 
between Giardia and his own loose stool (Dobell, 1920) while during the First World 
War, soldiers with diarrhea often had Giardia in their faeces that gave similar symptoms 
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when administered to laboratory animals. It was only from 1920 onwards that important 
influential researchers such as Miller and Dobell supported the idea of Giardia as a 
disease causing agent (Cox, 2002).  
In September 2004, giardiosis joined the WHO’s Neglected Diseases Initiative. This 
initiative consisted of a variety of parasitic, viral and bacterial diseases that mostly occur 
in developing countries and for which poverty influences the outcome of the disease 
(Savioli et al., 2006). In addition, the pathogens included in the initiative all represent an 
increasing global burden and prevent infected individuals from reaching their full 
potential. 
A Giardia infection in humans can occur in different forms. On the one hand, 
asymptomatic carriers harbor infections that go by unnoticed, while in others, Giardia 
can cause acute or even chronic disease. Symptomatic disease usually occurs after a 
prepatent period of 3 to 20 days (Farthing, 1996). The most common symptom associated 
with giardiosis is diarrhea, followed closely by weight loss. Others include epigastric 
pain, flatulence, nausea, vomiting and steatorrhea (Eckmann, 2003; Robertson et al., 
2010; Thompson et al., 1993; Troeger et al., 2007). Although infections can be self-
limiting, a proportion of patients without apparent immunodeficiencies develop chronic 
disease (Nash et al., 1987; Rendtorff, 1954). In these cases a persistent diarrhea is 
present, often resulting in profound weight loss. Especially infants and young children are 
at risk of developing clinical giardiosis and chronic infections can lead to malnutrition, 
growth impairment and even poor cognitive development (Berkman et al., 2002; Fraser et 
al., 2000). In a study done by Muhsen and Levine (2012), a systematic literature review 
and meta-analysis suggested an important role for Giardia in persistent diarrhea in 
children in nonindustrialized settings, but not in acute diarrhea.  
Why exactly there is such great discrepancy in the way infected hosts respond is 
still unclear. Numerous attempts have been made to link these differences to the different 
Giardia assemblages that can infect humans. However, the outcomes of these studies are 
inconclusive. While in several studies patients infected by assemblage A appeared more 
likely to show clinical signs and assemblage B was associated with asymptomatic cases 
(Perez Cordon et al., 2008; Read et al., 2002; Sahagun et al., 2008), other studies revealed 
the opposite (Al-Mohammed, 2011; Mahdy et al., 2009) with assemblage B causing more 
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persistent diarrhea (Homan and Mank, 2001; Muhsen and Levine, 2012). Besides 
assemblage related parasite factors, the appearance of a new genotype in an area where a 
different genotype was endemic, the possible synergistic effect of different assemblages 
in a single host, infection pressure and multiple parasitic factors (such as rate of 
multiplication, ability to evade immunity and others) have all been considered as possible 
causes of the variability in host response (Robertson et al., 2010; Tungtrongchitr et al., 
2010). 
In contrast to the situation in humans, Giardia infections in ruminants typically 
lead to a chronic infection with potential intermittent symptoms in all infected 
individuals. In cattle, infections lead to cyst excretions that can last well over 100 days in 
both dairy and beef cattle (O'Handley and Olson, 2006). This type of chronicity has also 
been documented in goats (Koudela and Vitovec, 1998) and sheep (Sweeny et al., 2011). 
An infection with Giardia in these hosts species can cause ill thrift and diarrhea that is 
unresponsive to antibiotics or coccidiostatics and that is pasty to fluid with a mucoid 
appearance. The potential impact of such infection on production is of particular interest. 
Experimental Giardia infections in goat kids and lambs resulted in a decreased feed 
efficiency with decreased weight gain and lowered carcass weight (Aloisio et al., 2006; 
Koudela and Vitovec, 1998; Olson et al., 1995). Whether a difference in clinical outcome 
occurs between different assemblages in ruminants is not known.  
Although often remaining without clinical symptoms, Giardia infection in dogs 
and cats can present itself with a soft watery diarrhea or steatorrhea and an abdominal 
discomfort or pain. In immunocompetent animals, these symptoms are usually self-
limiting (Epe et al. , 2010; Tangtrongsup and Scorza, 2010).  
As is the case with clinical symptoms, the pathological abnormalities caused by 
Giardia in the intestine can also vary substantially between infected individuals. A 
summary of the observations previously published is shown in Table 1.2. A study 
performed on duodenal biopsies of infected human patients could not find any association 
between the presence of Giardia and histological changes (Oberhuber and Stolte, 1990). 
Work done on biopsies of 567 infected people revealed a normal light microscopic 
appearance of the duodenal mucosa in 96.3% of the cases, with the remaining 3.7 percent 
showing only mild villous shortening and mild inflammation of the lamina propria 
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(Oberhuber et al., 1997). In ten children with chronic diarrhea caused by Giardia, three 
had completely normal jejunal tissue, five children showed mild to moderate 
morphological abnormalities while two showed more severe pathologies (Judd et al., 
1983). Troeger et al. (2007) investigated duodenal biopsies of 13 patients with chronic 
giardiosis. An altered mucosal architecture was seen with a reduction of villous surface 
area by 50% when comparing tissue of the infected patients to the control tissue. In 
addition, an epithelial barrier dysfunction was detected, likely caused by increased 
apoptosis of enterocytes as well as a reduced expression of the tight junctional protein 
claudin 1. In addition, a reduced absorption of Na-glucose and an increased anion 
secretion were also detected.  
In ruminants, a moderate villous atrophy and inflammatory infiltration has been 
seen in the small intestine of goat kids infected with Giardia in samples taken on day 21 
and 28 post infection (Koudela and Vitovec, 1998). Work done in calves found villus 
atrophy and increased numbers of intraepithelial lymphocytes after less then four weeks 
of infection (Ruest et al., 1997), while treatment with fenbendazole and the subsequent 
clearance of the parasite increased the brush border surface area and intestinal 
disaccharidase activity in previously infected animals (O'Handley et al., 2001). In 
contrast to these findings, Barigye et al. (2008) described the absence of histological 
changes in the intestine of four out of five calves infected with G. duodenalis assemblage 
E.  
In addition to the above mentioned in vivo studies in natural hosts, a large number 
of in vitro- and animal model studies have been performed in an attempt to unravel the 
underlying mechanisms in the pathogenesis of Giardia, focusing on the epithelial barrier 
malfunction in particular. In vitro exposure of human intestinal cell lines to G. duodenalis 
trophozoites resulted in increased enterocyte apoptosis rates in a caspase-3 dependent 
manner (Chin et al., 2002; Panaro et al., 2007). Similar, microarray analysis showed an 
up-regulated expression of genes associated with apoptosis in human Caco-2 intestinal 
epithelial cells after exposure to G. duodenalis (Roxstrom-Lindquist et al., 2005). Besides 
apoptosis, the co-culture of trophozoites with human small intestinal cell lines affected 
important junctional and cytoskeletal elements such as zonula occludens-1, α-actinin and 
cellular F-actin (Buret et al., 2002; Scott et al., 2002; Teoh et al., 2000). Work done in a 
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G. muris-mouse infection model showed that, in response to the increased permeability of 
the epithelium, T cells, and more specifically CD8+ T cells, are activated and cause brush 
border microvilli shortening and the subsequent reduction of the total intestinal 
absorptive area (Scott et al., 2000). The loss of microvilli coincided with a deficiency in a 
variety of brush border enzymes such as lipase, disaccharidase, maltase and sucrase as 
was shown in studies done on laboratory animals (Buret et al., 1991; Cevallos et al., 
1995; Gillon et al., 1982). Brush border abnormalities additionally cause an impaired 
absorption of water, glucose and electrolytes in infected rodents, creating an osmotic 
gradient that pulls water into the intestinal lumen (Cevallos et al., 1995; Scott et al., 2000; 
Scott et al., 2004). Another diarrhea-inducing characteristic of a Giardia infection is the 
increased intestinal transit. Research revealed that Giardia influences transit by inducing 
mast cell degranulation that in its turn causes an enhanced contraction of the smooth 
muscles in the intestinal wall in G. duodenalis infected mice (Li et al., 2007). These 
contractions are both responsible for abdominal cramps and for reducing the time 
available for water reabsorption and nutrient uptake in the intestine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	  	  	  
	  
Table 1.2. Giardia duodenalis pathogenesis and pathology in natural hosts 
 
Host  Individuals analyzed 
(n) 
Infection & Assemblage Pathology References 
Human 567 patients Natural 96.3% of patients normal mucosa, in 3.7% of 
patients, mild shortening of villi 
(Oberhuber and 
Stolte, 1997) 
 10 children Natural with chronic diarrhea 
Assemblage unknown 
n = 5 mild, n = 2 severe, n=3 no abnormalities (Judd et al., 1983) 
 13 patients Chronic giardiosis 
Assemblage unknown 
 
All subjects: reduction in villous surface area, 
reduced expression of CLDN1, intestinal 
malabsorption and increased anion secretion 
(Troeger et al., 2007) 
Goat  8 goat kids Dose: 3x106 Giardia cysts  
Assemblage unknown  
Moderate atrophy on day 21 and 28 pi  (Koudela and 
Vitovec, 1998) 
Cattle  10 calves 4 weeks of natural infection 
Assemblage unknown 
All infected calves villus atrophy and 
increased IEL 
(Ruest et al., 1997) 
 6 calves in each group 105 cyst, after 10 days: 
fenbendazole treatment 
Assemblage unknown 
Higher microvillus surface area and increased 
disaccharidase activity in treated group, no 
difference in villus height between treated and 
non-treated group. 
(O'Handley et al., 
2001) 
 5 calves Natural infections 
Assemblage E 
Changes could not be definitively attributed 
to Giardia 
(Barigye et al., 2008) 
 5 calves 1.5-5.1 x 106 cysts 
“bovine isolate” 
Intact microvilli on Giardia attachment sites (Taminelli et al., 
1989) 
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1.6. Anti-Giardia immune response 
 
The immune development process can vary substantially between infected 
individuals, from a fast elimination to a chronic disease, depending on the host 
species. In the following paragraph a summary will be made of the data available 
concerning immune responses against and induced by Giardia, more specifically in 
humans, ruminants and rodents. In addition, a summary of data collected during in 
vivo experiments is made in Table 1.3. 
 
1.6.1.  Humans 
 
The information on cellular immune responses and cytokine production during 
Giardia infection in humans is still very limited. Analysis on sera of infected patients 
showed elevated levels of IL-5, IL-6 and IFN-γ (Matowicka-Karna et al., 2009). In a 
study done by Ebert (1999), peripheral blood and intestinal lymphocytes from naïve 
individuals demonstrated proliferation of CD4+ T cells and secretion of IFN-γ in 
response to Giardia trophozoites. In a preliminary study done by Gottstein et al. 
(1991) and work done by Hanevik et al. (2011), a role was seen for CD4+ T cells in 
the memory response after human giardiosis. Analysis of antibody production by B 
cells showed the generation of parasite specific IgA, IgM and IgG’s that were present 
in both serum and mucosal secretions, such as saliva and breast milk, in reaction to 
infection (Faubert et al., 2000). The importance of antibodies in immune development 
was further hypothesized based on higher prevalences of chronic Giardia infections in 
patients with common variable immunodeficiency and x-linked agammaglobulinemia 
compared to healthy patients. However, since additional defects in the immune 
system exist in both these syndromes, in addition to the inability to produce 
antibodies, further research is needed to fully understand the role of antibodies in the 
immune response (Faubert, 2000).  
 
1.6.2. Ruminants 
 
Research on the immune response to Giardia in ruminants has mainly 
focussed on the humoral responses. In a study on calves, O'Handley et al. (2003) 
showed that parasite-specific antibody titers in serum of infected animals did not 
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increase during a four-month period. Based on this observation, the authors concluded 
that calves do not mount a significant humoral immune response against G. 
duodenalis, likely due to the extracellular location of the parasite or to the sequential 
expression of distinct variant surface proteins (VSP’s). Importantly, the cyst 
excretions at the end of the 4 months period were not decreased compared to the start 
of the trial, suggesting that the animals did not yet acquire immunity. Similar results 
were also seen in a study on lambs which were followed during 11 weeks of infection. 
Analysis of parasite-specific antibody titers in serum showed no changes in IgM 
levels and only a small increase for IgG and IgA at week 5, 9 and 11 post infection, 
prompting the authors to conclude that the lack of a clear immune response was 
responsible for the chronicity of infection (Yanke et al., 1998). More recently, the 
kinetics of the immune response in infected cattle were monitored until the animals 
showed immune protection against re-infection, which occurred after approximately 3 
months of infection (Grit et al., 2014). The first signs of an adaptive immune response 
only became visible after approximately 9 weeks of infection, as characterized by a 
significant proliferation of IL-17A producing CD4+ αβ T cells following in vitro 
restimulation of peripheral blood mononuclear cells (PBMC) with G. duodenalis 
antigens. From 11 weeks post-infection onwards, a parasite-specific IgG1 and IgA 
response was detectable. 
 
1.6.3.  Rodents 
 
Although G. duodenalis is not a natural parasite species of rodents, both 
gerbils and mice have been used extensively to investigate Giardia-host interactions. 
Gerbils can be infected orally with G. duodenalis cysts or trophozoites. This results in 
an infection with cysts detectable in the faeces of the animals for around 3 to 4 weeks. 
The trophozoites are eliminated from the intestine around day 30 pi (Belosevic et al., 
1983). The observations made in gerbils following a G. duodenalis infection are 
summarized in Table 1.3. In several studies, an increased production of mucus or an 
increase in the number of goblet cells counted in the intestine were detected in the 
presence of Giardia (Araujo et al., 2008; Ventura et al., 2013). Around 21 days pi, 
higher mast cell counts could be detected in the intestine (Hardin et al., 1997). 
Infection also induces the production and secretion of intestinal IgA after about a 
week of infection. In addition, serum antibodies were observed after 3 weeks 
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(Amorim et al., 2010). In the abovementioned studies, the G. duodenalis isolates that 
have been used are all of assemblage A (human isolate). It was determined by Bénéré 
et al. (2010) that infection can also be established using assemblage B from human 
origin and E obtained from cattle.  
In contrast to gerbils, the infection of mice with G. duodenalis is somewhat 
more difficult. Trophozoites of the human isolate GS(M) (assemblage B) need to be 
administrated through oral gavage in order to establish a patent infection. The 
infection can subsequently be divided into three phases: the establishment phase with 
the presence of large amounts of trophozoites in the intestine followed by the second 
phase, after approximately 13 days, during which the trophozoite numbers start to 
drop and finally the last phase characterized by cure or chronic infection depending 
on the mouse strain used (Byrd et al., 1994). The observations made in mice 
following a G. duodenalis challenge are summarized in Table 1.3. T-cell dependent 
mechanisms seem to be essential in the control of giardiosis in mice, as shown by the 
development of chronic infections in scid mice, mice treated with anti-CD4 and mice 
lacking the T cell receptor gene (Singer and Nash, 2000). Mice deficient in either 
TNF-α or IL-6 were also more susceptible to G. duodenalis infection compared to 
wild-type control mice, as shown by the delayed parasite elimination (Zhou et al., 
2003; Singer and Kamda, 2009). In contrast, IL-4 or IFN-γ deficient mice were still 
able to control a Giardia infection similar as wild-type mice (Singer and Nash, 2000).  
Comparable to what was seen in gerbils, a possible effector mechanism in the 
response to G. duodenalis  in mice is the recruitment and activation of mucosal mast 
cells. The involvement of mast cells was supported by the fact that mast cell-deficient 
c-kitw/wv mice, who can not mount a mast cell response, were unable to eliminate a G. 
duodenalis infection in the normal timespan (Li et al., 2004). The role of antibodies 
and B cells in the clearance of a G. duodenalis infection in mice is still somewhat 
unclear. Whereas mice genetically deficient for IgA were unable to eradicate infection 
(Langford et al., 2002), mice lacking the polymeric immunoglobulin receptor (pIgR), 
responsible for transport of IgA and IgM to the intestinal lumen, had no problem 
eradicating a G. duodenalis infection (Davids et al., 2006). However, it should be 
stated that these mice likely still had a low level of IgA present in the intestinal 
lumen. Concerning B cells, although Li et al. (2004) showed that infection of mice 
deficient in B cells resulted in a chronic low-level infection, a study done by Singer 
and Nash (2000) indicated no difference in parasite clearance in G. duodenalis 
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infected B cell deficient mice compared to wild type controls. Finally, infection 
experiments in mice lacking inducible nitric oxide synthase (iNOS), necessary for NO 
production, or mice that were unable to produce active α-defensins were still able to 
control the infection (Aley et al., 1994; Eckmann, 2003), suggesting that these factors 
are not involved in the protective immune response. 
An alternative way to unravel the Giardia-host interplay is to use the rodent-specific 
species G. muris to infect mice. The life cycle and infection process of this parasite is 
basically identical to that of G. duodenalis in natural hosts, with the only difference 
that most mice strains are able to clear a G. muris infection after 3 to 6 weeks of 
contact with the parasite. Regarding the immune response, earlier work identified 
CD4+ T cells as important elements in parasite clearance, shown by the development 
of prolonged infections in nude mice (Stevens et al., 1978) and mice depleted of T 
helper cells (Heyworth et al., 1987). Mesenteric lymph node derived T cells from G. 
muris infected mice that were stimulated with ConA secreted both IFN-γ and IL-5 in 
resistant mice strains and only IL-5 in susceptible strains (Venkatesan et al., 1996). 
Con A stimulation of mucosal TH-cells resulted in higher amounts of IL-4 and IFN-γ 
secretion in infected mice compared to uninfected controls (Djamiatun and Faubert, 
1998). In addition, anti-IFNγ treatment resulted in higher parasite numbers in mice 
with a C57Bl/6 background, but not BALB/c (Venkatesan et al., 1996). Several 
studies have also focussed on the role of B cells and antibody production in the 
elimination of a G. muris infection. Concerning B-cells, a central role for these cells 
was shown by the inability of X-linked immunodeficient mice (xid) (Skea and 
Underdown, 1991) and B cell KO mice (Snider et al., 1988) to clear an infection. 
However, it should be noted that in a study done by Singer and Nash (2000), no 
difference in parasite clearance could be seen when comparing B cell deficient to 
wild-type mice, a similar result as obtained for G. duodenalis in mice (see above). In 
addition, although xid mice are unable to eliminate a primary infection, they are 
resistant to a secondary challenge infection (Skea and Underdown, 1991). Looking 
more closely at antibodies, the production and secretion in the gut lumen of IgG and 
IgA in particular seems to be a key factor in the clearance of a G. muris infection 
(Belosevic et al., 1994; Heyworth, 1986). In contrast to G. duodenalis infected pIgR-
deficient mice, loss of this receptor severely affected the ability of mice to clear a G. 
muris infection (Davids et al., 2006), hinting that G. muris might be more resistant to 
certain immune responses than G. duodenalis.  
Table 1.3. Immune responses against Giardia spp. 	  
	   	  
 Human Ruminant Rodent 
 G. duodenalis G. duodenalis G. duodenalis G. muris 
Innate immunity     
Goblet cells, mucin 
production 
  Increased in infected gerbils (Araujo, 
2008; Ventura, 2013) 
 
T cells & cytokines     
T cells   Proliferation IL-17 producing 
CD4+ γδ T cells after in vitro 
stimulation with trophozoites 
(cow) (Grit et al., 2014) 
Chronic infection in scid, anti-CD4 
treated & T cell receptor deficient mice 
(Singer et al., 2000) 
Prolonged infections in CD4 depleted mice 
(Heyworth et al., 1987) 
TNF-α   TNF deficient mice show delayed 
parasite elimination (Zhou et al., 2003) 
 
IL-5 Elevated in sera of infected 
patients (Ebert et al., 1999) 
   
IL-6 Elevated in sera of infected 
patients (Ebert et al., 1999) 
 
 IL-6 deficient mice show delayed 
parasite elimination (Singer et al., 2009) 
 
IFN-γ Elevated in sera of infected 
patients (Ebert et al., 1999) 
  Higher parasite numbers in anti-IFN-γ treated 
mouse strains (Venkatesen et al., 1996) 
B cells & antibodies     
Parasite-specific IgA, 
IgM and IgG’s 
Found in sera, mucosal 
secretions, milk and saliva 
(Faubert et al., 2000)) 
Detectable in serum from 11 
weeks p.i. onwards (Grit et al., 
2014) 
Production and secretion of IgA starting 
1 week p.i. (gerbil) (Amorim et al., 
2010) 
Production of IgA important for parasite  
clearance in mice (Belosevic et al., 1994) 
   IgA deficient mice are unable to clear 
infection (Langford et al., 2002) 
 
B cells   Contradicting results for B cell 
deficiency in mice (Li et al., 2004; 
Singer et al., 2000) 
Contradicting results in mice (Skea et al., 1991; 
Singer et al., 2000) 
Effector mechanism     
Mast cells   More in infected gerbils (Hardin et al., 
1997) 
 
22	   Chapter 1	  	  
	  
1.6.4. in vitro assays 
 
In addition to the in vivo experiments summarized above, a large number of papers 
have been published on the use of in vitro assays to investigate particular aspects of 
the host-Giardia relationship.  
First, the role of mucins was investigated by looking at their effect on 
trophozoite attachment to an artificial surface. Whereas Roskens and Erlandsen 
(2002) described an inhibition of attachment in the presence of mucins purified from 
bovine submaxillary glands and porcine stomachs, an increased attachment to glass 
was actually seen in the presence of human intestinal mucins by Zenian and Gillin 
(1985) and Gault et al. (1987) reported that in vitro co-culture of trophozoites with 
human mucus even stimulated giardial growth.  
Several studies have also used in vitro assays to analyse the role of dendritic 
cells in the initiation of the adaptive immune response against Giardia. It was shown 
by Kamda and Singer (2009) that Giardia trophozoites and different protein fractions 
of Giardia inhibited murine bone-marrow derived DCs to elicit a Th1 inflammatory 
pathway, with decreased IL-12 and increased IL-10 production. Obendorf et al. 
(2013) reported increased expression of CD25, CD83, and CD86, and secretion of IL-
12, IL-23 and IL-10 by human dendritic cells incubated in the presence of Toll-like 
receptor 2 ligands and G. duodenalis. More recently, it was shown that incubation 
with G. duodenalis trophozoites stimulated partial maturation of bovine dendritic cells 
associated with altered cytokine secretion and induction of T-cell proliferation (Grit et 
al., 2014). So in contrast to the study of Kamda and Singer (2009), no regulatory or 
inhibitory effect on dendritic cells was found in cattle.  
Finally, several in vitro studies have also been performed to identify possible 
effector mechanisms in the protection against Giardia. The addition of a NO releasing 
compound to a trophozoite culture was shown to have a cytostatic effect on the 
parasite, yet without achieving cytotoxicity (Eckmann et al., 2000). However, as 
previously mentioned, mice lacking inducible nitric oxide synthase (iNOS), were still 
able to control the infection (Aley et al., 1994). It is therefore questionable whether 
NO actually has a role in the protection against Giardia in vivo. Additional in vitro 
assays indicated that human peripheral blood macrophages were able to adhere to and 
ingest Giardia  trophozoites (Hill and Pearson, 1987). However, the low efficiency by 
which trophozoites are ingested (less then one parasite per macrophage) and the high 
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trophozoite/macrophage ratio in the intestine are not in favor of macrophages being a 
major player in the effector mechanism (Eckmann, 2003). 
 
1.7. Conclusion 
 
Although our knowledge on this omnipresent parasite has increased 
dramatically in the last decade, certain aspects still remain unclear. This is particularly 
the case for the differences that exist both between and within host species in their 
ability to acquire immunity. Whereas some species, such as rodents and in certain 
cases also humans, are able to eliminate the parasite in a matter of a few weeks, other 
host species such as cattle develop a chronic infection that lasts for several months. 
Comparative analysis of the immunological mechanisms and pathways involved in 
the immune development process in different host species is therefore needed to fully 
unravel this intriguing aspect of Giardia infections in mammals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24	   Chapter 1	  	  
	  
1.8.  References 
 
Adam, R.D., 2001, Biology of Giardia lamblia. Clin Microbiol Rev 14, 447-475. 
Al-Mohammed, H.I., 2011, Genotypes of Giardia intestinalis clinical isolates of 
gastrointestinal symptomatic and asymptomatic Saudi children. Parasitol Res 
108, 1375-1381. 
Aley, S.B., Zimmerman, M., Hetsko, M., Selsted, M.E., Gillin, F.D., 1994, Killing of 
Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun 
62, 5397-5403. 
Aloisio, F., Filippini, G., Antenucci, P., Lepri, E., Pezzotti, G., Caccio, S.M., Pozio, 
E., 2006, Severe weight loss in lambs infected with Giardia duodenalis 
assemblage B. Vet Parasitol 142, 154-158. 
Amorim, R.M., Silva, D.A., Taketomi, E.A., Morato, M.G., Mundim, M.J., Ribeiro, 
D.P., Oliveira, T.C., Viana, J.C., Gomes, M.A., Cury, M.C., 2010, Giardia 
duodenalis: kinetics of cyst elimination and the systemic humoral and 
intestinal secretory immune responses in gerbils (Meriones unguiculatus) 
experimentally infected. Exp. Parasitol. 125, 297-303. 
Andersen, Y.S., Gillin, F.D., Eckmann, L., 2006, Adaptive immunity-dependent 
intestinal hypermotility contributes to host defense against Giardia spp. Infect 
Immun 74, 2473-2476. 
Araujo, N.S., Mundim, M.J., Gomes, M.A., Amorim, R.M., Viana, J.C., Queiroz, 
R.P., Rossi, M.A., Cury, M.C., 2008, Giardia duodenalis: pathological 
alterations in gerbils, Meriones unguiculatus, infected with different dosages 
of trophozoites. Exp. Parasitol. 118, 449-457. 
Armson, A., Yang, R., Thompson, J., Johnson, J., Reid, S., Ryan, U.M., 2009, Giardia 
genotypes in pigs in Western Australia: prevalence and association with 
diarrhea. Exp. Parasitol. 121, 381-383. 
Barigye, R., Dyer, N.W., Newell, T.K., Khaitsa, M.L., Trout, J.M., Santin, M., Fayer, 
R., 2008, Molecular and immunohistochemical detection of assemblage E, 
Giardia duodenalis in scouring North Dakota calves. Vet Parasitol 157, 196-
202. 
Belosevic, M., Faubert, G.M., Dharampaul, S., 1994, Antimicrobial action of 
antibodies against Giardia muris trophozoites. Clin Exp Immunol 95, 485-489. 
Belosevic, M., Faubert, G.M., MacLean, J.D., Law, C., Croll, N.A., 1983, Giardia 
lamblia infections in Mongolian gerbils: an animal model. J Infect Dis 147, 
222-226. 
Benere, E., Geurden, T., Robertson, L., Van Assche, T., Cos, P., Maes, L., 2010, 
Infectivity of Giardia duodenalis Assemblages A and E for the gerbil and 
axenisation of duodenal trophozoites. Parasitol Int 59, 634-637. 
Berkman, D.S., Lescano, A.G., Gilman, R.H., Lopez, S.L., Black, M.M., 2002, 
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy 
on cognition in late childhood: a follow-up study. Lancet 359, 564-571. 
Bingham, A.K., Jarroll, E.L., Jr., Meyer, E.A., Radulescu, S., 1979, Giardia sp.: 
physical factors of excystation in vitro, and excystation vs eosin exclusion as 
determinants of viability. Exp. Parasitol. 47, 284-291. 
Boreham, P.F., Upcroft, J.A., Upcroft, P., 1990, Changing approaches to the study of 
Giardia epidemiology: 1681-2000. Int. J. Parasit. 20, 479-487. 
Buret, A., Gall, D.G., Olson, M.E., 1991, Growth, activities of enzymes in the small 
intestine, and ultrastructure of microvillous border in gerbils infected with 
Giardia duodenalis. Parasitol Res 77, 109-114. 
Giardia and host responses	   25	  	  
	   	  
Buret, A.G., Mitchell, K., Muench, D.G., Scott, K.G., 2002, Giardia lamblia disrupts 
tight junctional ZO-1 and increases permeability in non-transformed human 
small intestinal epithelial monolayers: effects of epidermal growth factor. 
Parasitology 125, 11-19. 
Byrd, L.G., Conrad, J.T., Nash, T.E., 1994, Giardia lamblia infections in adult mice. 
Infect Immun 62, 3583-3585. 
Cavalier-Smith, T., 2003, Protist phylogeny and the high-level classification of 
Protozoa. European Journal of Protistology 39, 338-348. 
Cevallos, A., Carnaby, S., James, M., Farthing, J.G., 1995, Small intestinal injury in a 
neonatal rat model of giardiasis is strain dependent. Gastroenterology 109, 
766-773. 
Chin, A.C., Teoh, D.A., Scott, K.G., Meddings, J.B., Macnaughton, W.K., Buret, 
A.G., 2002, Strain-dependent induction of enterocyte apoptosis by Giardia 
lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. 
Infect Immun 70, 3673-3680. 
Cotton, J.A., Beatty, J.K., Buret, A.G., 2011, Host parasite interactions and 
pathophysiology in Giardia infections. Int. J. Parasit. 41, 925-933. 
Cox, F.E., 2002, History of human parasitology. Clin Microbiol Rev 15, 595-612. 
Davids, B.J., Palm, J.E., Housley, M.P., Smith, J.R., Andersen, Y.S., Martin, M.G., 
Hendrickson, B.A., Johansen, F.E., Svard, S.G., Gillin, F.D., Eckmann, L., 
2006, Polymeric immunoglobulin receptor in intestinal immune defense 
against the lumen-dwelling protozoan parasite Giardia. J Immunol 177, 6281-
6290. 
Deng, M.Y., Cliver, D.O., 1992, Degradation of Giardia lamblia cysts in mixed 
human and swine wastes. Appl Environ Microbiol 58, 2368-2374. 
Djamiatun, K., Faubert, G.M., 1998, Exogenous cytokines released by spleen and 
Peyer's patch cells removed from mice infected with Giardia muris. Parasite 
Immunol 20, 27-36. 
Dobell, C., 1920, The Discovery of the Intestinal Protozoa of Man. Proc R Soc Med 
13, 1-15. 
Ebert, E.C., 1999, Giardia induces proliferation and interferon gamma production by 
intestinal lymphocytes. Gut 44, 342-346. 
Eckmann, L., 2003, Mucosal defences against Giardia. Parasite Immunol 25, 259-270. 
Eckmann, L., Laurent, F., Langford, T.D., Hetsko, M.L., Smith, J.R., Kagnoff, M.F., 
Gillin, F.D., 2000, Nitric oxide production by human intestinal epithelial cells 
and competition for arginine as potential determinants of host defense against 
the lumen-dwelling pathogen Giardia lamblia. J Immunol 164, 1478-1487. 
Ekdahl, K., Andersson, Y., 2005, Imported giardiasis: impact of international travel, 
immigration, and adoption. Am J Trop Med Hyg 72, 825-830. 
Elmendorf, H.G., Dawson, S.C., McCaffery, J.M., 2003, The cytoskeleton of Giardia 
lamblia. Int. J. Parasit. 33, 3-28. Epe,	  C.,	  Rehkter,	  G.,	  Schnieder,	  T.,	  Lorentzen,	  L.,	  Kreienbrock,	  L.,	  2010,	  Giardia	  in	  symptomatic	   dogs	   and	   cats	   in	   Europe-­‐-­‐results	   of	   a	   European	   study.	   Vet	  Parasitol	  173,	  32-­‐38.	  
Erlandsen, S.L., Bemrick, W.J., 1987, SEM evidence for a new species, Giardia 
psittaci. J Parasitol 73, 623-629. 
Ey, P.L., Mansouri, M., Kulda, J., Nohynkova, E., Monis, P.T., Andrews, R.H., 
Mayrhofer, G., 1997, Genetic analysis of Giardia from hoofed farm animals 
reveals artiodactyl-specific and potentially zoonotic genotypes. J Eukaryot 
Microbiol 44, 626-635. 
26	   Chapter 1	  	  
	  
Farthing, M.J., 1996, Giardiasis. Gastroenterol Clin North Am 25, 493-515. 
Faubert, G., 2000, Immune response to Giardia duodenalis. Clin Microbiol Rev 13, 
35-54, table of contents. 
Feely, D.E., 1988, Morphology of the cyst of Giardia microti by light and electron 
microscopy. J Protozool 35, 52-54. 
Feng, Y., Xiao, L., 2011, Zoonotic potential and molecular epidemiology of Giardia 
species and giardiasis. Clin Microbiol Rev 24, 110-140. 
Field, V., Gautret, P., Schlagenhauf, P., Burchard, G.D., Caumes, E., Jensenius, M., 
Castelli, F., Gkrania-Klotsas, E., Weld, L., Lopez-Velez, R., de Vries, P., von 
Sonnenburg, F., Loutan, L., Parola, P., 2010, Travel and migration associated 
infectious diseases morbidity in Europe, 2008. BMC Infect Dis 10, 330. 
Fletcher, S.M., Stark, D., Harkness, J., Ellis, J., 2012, Enteric protozoa in the 
developed world: a public health perspective. Clin Microbiol Rev 25, 420-449. 
Fraser, D., Bilenko, N., Deckelbaum, R.J., Dagan, R., El-On, J., Naggan, L., 2000, 
Giardia lamblia carriage in Israeli Bedouin infants: risk factors and 
consequences. Clin Infect Dis 30, 419-424. 
Gault, M.J., Gillin, F.D., Zenian, A.J., 1987, Giardia lamblia: stimulation of growth 
by human intestinal mucus and epithelial cells in serumfree medium. Exp. 
Parasitol. 64, 29-37. 
Geurden, T., Geldhof, P., Levecke, B., Martens, C., Berkvens, D., Casaert, S., 
Vercruysse, J., Claerebout, E., 2008, Mixed Giardia duodenalis assemblage A 
and E infections in calves. Int. J. Parasit. 38, 259-264. 
Geurden, T., Vercruysse, J., Claerebout, E., 2010, Is Giardia a significant pathogen in 
production animals? Exp. Parasitol. 124, 98-106. 
Gillin, F.D., Boucher, S.E., Rossi, S.S., Reiner, D.S., 1989, Giardia lamblia: the roles 
of bile, lactic acid, and pH in the completion of the life cycle in vitro. Exp. 
Parasitol. 69, 164-174. 
Gillin, F.D., Reiner, D.S., Boucher, S.E., 1988, Small-intestinal factors promote 
encystation of Giardia lamblia in vitro. Infect Immun 56, 705-707. 
Gillon, J., Al Thamery, D., Ferguson, A., 1982, Features of small intestinal pathology 
(epithelial cell kinetics, intraepithelial lymphocytes, disaccharidases) in a 
primary Giardia muris infection. Gut 23, 498-506. Gottstein,	  B.,	  Stocks,	  N.I.,	  Shearer,	  G.M.,	  Nash,	  T.E.,	  1991,	  Human	  cellular	  immune	  response	  to	  Giardia	  lamblia.	  Infection	  19,	  421-­‐426. 
Grit, G.H., Benere, E., Ehsan, A., De Wilde, N., Claerebout, E., Vercruysse, J., Maes, 
L., Geurden, T., 2012, Giardia duodenalis cyst survival in cattle slurry. Vet 
Parasitol 184, 330-334. Grit,	   G.H.,	   Van	   Coppernolle,	   S.,	   Devriendt,	   B.,	   Geurden,	   T.,	   Dreesen,	   L.,	   Hope,	   J.,	  Vercruysse,	   J.,	   Cox,	   E.,	   Geldhof,	   P.,	   Claerebout,	   E.,	   2014,	   Evaluation	   of	  cellular	   and	   humoral	   systemic	   immune	   response	   against	   Giardia	  duodenalis	  infection	  in	  cattle.	  Vet	  Parasitol	  202,	  145-­‐155.	  Hanevik,	   K.,	   Kristoffersen,	   E.,	   Svard,	   S.,	   Bruserud,	   O.,	   Ringqvist,	   E.,	   Sornes,	   S.,	  Langeland,	   N.,	   2011,	   Human	   cellular	   immune	   response	   against	   Giardia	  lamblia	  5	  years	  after	  acute	  giardiasis.	  J	  Infect	  Dis	  204,	  1779-­‐1786. 
Hardin, J.A., Buret, A.G., Olson, M.E., Kimm, M.H., Gall, D.G., 1997, Mast cell 
hyperplasia and increased macromolecular uptake in an animal model of 
giardiasis. J Parasitol 83, 908-912. 
Heyworth, M.F., 1986, Antibody response to Giardia muris trophozoites in mouse 
intestine. Infect Immun 52, 568-571. 
Giardia and host responses	   27	  	  
	   	  
Heyworth, M.F., 1992, Relative susceptibility of Giardia muris trophozoites to killing 
by mouse antibodies of different isotypes. J Parasitol 78, 73-76. 
Heyworth, M.F., Carlson, J.R., Ermak, T.H., 1987, Clearance of Giardia muris 
infection requires helper/inducer T lymphocytes. J Exp Med 165, 1743-1748. 
Hill DR, Pearson RD (1987) Ingestion of Giardia lamblia trophozoites by human 
mononuclear phagocytes. Infection and immunity 55: 3155-3161. 
Homan, W.L., Mank, T.G., 2001, Human giardiasis: genotype linked differences in 
clinical symptomatology. Int. J. Parasit. 31, 822-826. 
Homan, W.L., van Enckevort, F.H., Limper, L., van Eys, G.J., Schoone, G.J., 
Kasprzak, W., Majewska, A.C., van Knapen, F., 1992, Comparison of Giardia 
isolates from different laboratories by isoenzyme analysis and recombinant 
DNA probes. Parasitol Res 78, 316-323. 
Hoque, M.E., Hope, V.T., Kjellstrom, T., Scragg, R., Lay-Yee, R., 2002, Risk of 
giardiasis in Aucklanders: a case-control study. Int J Infect Dis 6, 191-197. 
Hoque, M.E., Hope, V.T., Scragg, R., Kjellstrom, T., 2003, Children at risk of 
giardiasis in Auckland: a case-control analysis. Epidemiol Infect 131, 655-
662. 
Judd, R., Deckelbaum, R.J., Weizman, Z., Granot, E., Ron, N., Okon, E., 1983, 
Giardiasis in childhood: poor clinical and histological correlations. Isr J Med 
Sci 19, 818-823. 
Kamda, J.D., Singer, S.M., 2009, Phosphoinositide 3-Kinase-Dependent Inhibition of 
Dendritic Cell Interleukin-12 Production by Giardia lamblia. Infect Immun 77, 
685-693. 
Karanis, P., Ey, P.L., 1998, Characterization of axenic isolates of Giardia intestinalis 
established from humans and animals in Germany. Parasitol Res 84, 442-449. 
Koh, W.H., Geurden, T., Paget, T., O'Handley, R., Steuart, R.F., Thompson, R.C., 
Buret, A.G., 2013, Giardia duodenalis assemblage-specific induction of 
apoptosis and tight junction disruption in human intestinal epithelial cells: 
effects of mixed infections. J Parasitol 99, 353-358. 
Koudela, B., Vitovec, J., 1998, Experimental giardiasis in goat kids. Vet Parasitol 74, 
9-18. 
Lane, S., Lloyd, D., 2002, Current trends in research into the waterborne parasite 
Giardia. Crit Rev Microbiol 28, 123-147. 
Langford, T.D., Housley, M.P., Boes, M., Chen, J., Kagnoff, M.F., Gillin, F.D., 
Eckmann, L., 2002, Central importance of immunoglobulin A in host defense 
against Giardia spp. Infect Immun 70, 11-18. 
Lasek-Nesselquist, E., Welch, D.M., Sogin, M.L., 2010, The identification of a new 
Giardia duodenalis assemblage in marine vertebrates and a preliminary 
analysis of G. duodenalis population biology in marine systems. Int. J. Parasit. 
40, 1063-1074. 
Li, E., Zhao, A., Shea-Donohue, T., Singer, S.M., 2007, Mast cell-mediated changes 
in smooth muscle contractility during mouse giardiasis. Infect Immun 75, 
4514-4518. 
Li, E., Zhou, P., Petrin, Z., Singer, S.M., 2004, Mast cell-dependent control of Giardia 
lamblia infections in mice. Infect Immun 72, 6642-6649. 
Maddox-Hyttel, C., Langkjaer, R.B., Enemark, H.L., Vigre, H., 2006, 
Cryptosporidium and Giardia in different age groups of Danish cattle and pigs 
- Occurrence and management associated risk factors. Vet Parasitol 141, 48-
59. 
28	   Chapter 1	  	  
	  
Mahdy, A.K., Surin, J., Mohd-Adnan, A., Wan, K.L., Lim, Y.A., 2009, Molecular 
characterization of Giardia duodenalis isolated from Semai Pahang Orang Asli 
(Peninsular Malaysia aborigines). Parasitology 136, 1237-1241. 
Matowicka-Karna, J., Dymicka-Piekarska, V., Kemona, H., 2009, IFN-gamma, IL-5, 
IL-6 and IgE in patients infected with Giardia intestinalis. Folia Histochem 
Cytobiol 47, 93-97. 
Meloni, B.P., Thompson, R.C., 1987, Comparative studies on the axenic in vitro 
cultivation of Giardia of human and canine origin: evidence for intraspecific 
variation. Trans R Soc Trop Med Hyg 81, 637-640. 
Monis, P.T., Andrews, R.H., Mayrhofer, G., Ey, P.L., 1999, Molecular systematics of 
the parasitic protozoan Giardia intestinalis. Mol Biol Evol 16, 1135-1144. 
Monis, P.T., Andrews, R.H., Mayrhofer, G., Mackrill, J., Kulda, J., Isaac-Renton, 
J.L., Ey, P.L., 1998, Novel lineages of Giardia intestinalis identified by 
genetic analysis of organisms isolated from dogs in Australia. Parasitology 
116 ( Pt 1), 7-19. 
Monis, P.T., Thompson, R.C., 2003, Cryptosporidium and Giardia-zoonoses: fact or 
fiction? Infect Genet Evol 3, 233-244. 
Morrison, H.G., McArthur, A.G., Gillin, F.D., Aley, S.B., Adam, R.D., Olsen, G.J., 
Best, A.A., Cande, W.Z., Chen, F., Cipriano, M.J., Davids, B.J., Dawson, 
S.C., Elmendorf, H.G., Hehl, A.B., Holder, M.E., Huse, S.M., Kim, U.U., 
Lasek-Nesselquist, E., Manning, G., Nigam, A., Nixon, J.E., Palm, D., 
Passamaneck, N.E., Prabhu, A., Reich, C.I., Reiner, D.S., Samuelson, J., 
Svard, S.G., Sogin, M.L., 2007, Genomic minimalism in the early diverging 
intestinal parasite Giardia lamblia. Science 317, 1921-1926. Muhsen,	   K.,	   Levine,	   M.M.,	   2012,	   A	   systematic	   review	   and	  meta-­‐analysis	   of	   the	  association	   between	   Giardia	   lamblia	   and	   endemic	   pediatric	   diarrhea	   in	  developing	  countries.	  Clin	  Infect	  Dis	  55	  Suppl	  4,	  S271-­‐293. 
Nash, T.E., Herrington, D.A., Losonsky, G.A., Levine, M.M., 1987, Experimental 
human infections with Giardia lamblia. J Infect Dis 156, 974-984. 
O'Handley, R.M., Buret, A.G., McAllister, T.A., Jelinski, M., Olson, M.E., 2001, 
Giardiasis in dairy calves: effects of fenbendazole treatment on intestinal 
structure and function. Int. J. Parasit. 31, 73-79. 
O'Handley, R.M., Ceri, H., Anette, C., Olson, M.E., 2003, Passive immunity and 
serological immune response in dairy calves associated with natural Giardia 
duodenalis infections. Vet Parasitol 113, 89-98. 
O'Handley, R.M., Olson, M.E., 2006, Giardiasis and cryptosporidiosis in ruminants. 
Veterinary Clinics of North America-Food Animal Practice 22, 623-+. 
Oberhuber, G., Kastner, N., Stolte, M., 1997, Giardiasis: a histologic analysis of 567 
cases. Scand J Gastroenterol 32, 48-51. 
Oberhuber, G., Stolte, M., 1990, Giardiasis: analysis of histological changes in biopsy 
specimens of 80 patients. J Clin Pathol 43, 641-643. 
Oberhuber, G., Stolte, M., 1997, Symptoms in patients with giardiasis undergoing 
upper gastrointestinal endoscopy. Endoscopy 29, 716-720. Olson,	  M.E.,	  Goh,	  J.,	  Phillips,	  M.,	  Guselle,	  N.,	  McAllister,	  T.A.,	  1999,	  Giardia	  cyst	  and	  Cryptosporidium	  oocyst	  survival	  in	  water,	  soil,	  and	  cattle	  feces.	  J	  Environ	  Qual	  28,	  1991-­‐1996. 
Olson, M.E., Leonard, N.J., Strout, J., 2010, Prevalence and diagnosis of Giardia 
infection in dogs and cats using a fecal antigen test and fecal smear. Can Vet J 
51, 640-642. 
Giardia and host responses	   29	  	  
	   	  
Olson, M.E., McAllister, T.A., Deselliers, L., Morck, D.W., Cheng, K.J., Buret, A.G., 
Ceri, H., 1995, Effects of giardiasis on production in a domestic ruminant 
(lamb) model. Am J Vet Res 56, 1470-1474. 
Olson, M.E., O'Handley, R.M., Ralston, B.J., McAllister, T.A., Thompson, R.C., 
2004, Update on Cryptosporidium and Giardia infections in cattle. Trends 
Parasitol 20, 185-191. 
Palm, D., Weiland, M., McArthur, A.G., Winiecka-Krusnell, J., Cipriano, M.J., 
Birkeland, S.R., Pacocha, S.E., Davids, B., Gillin, F., Linder, E., Svard, S., 
2005, Developmental changes in the adhesive disk during Giardia 
differentiation. Mol Biochem Parasitol 141, 199-207. 
Panaro, M.A., Cianciulli, A., Mitolo, V., Mitolo, C.I., Acquafredda, A., Brandonisio, 
O., Cavallo, P., 2007, Caspase-dependent apoptosis of the HCT-8 epithelial 
cell line induced by the parasite Giardia intestinalis. FEMS Immunol Med 
Microbiol 51, 302-309. 
Perez Cordon, G., Cordova Paz Soldan, O., Vargas Vasquez, F., Velasco Soto, J.R., 
Sempere Bordes, L., Sanchez Moreno, M., Rosales, M.J., 2008, Prevalence of 
enteroparasites and genotyping of Giardia lamblia in Peruvian children. 
Parasitol Res 103, 459-465. 
Plutzer, J., Ongerth, J., Karanis, P., 2010, Giardia taxonomy, phylogeny and 
epidemiology: Facts and open questions. Int J Hyg Environ Health 213, 321-
333. 
Read, C., Walters, J., Robertson, I.D., Thompson, R.C., 2002, Correlation between 
genotype of Giardia duodenalis and diarrhoea. Int. J. Parasit. 32, 229-231. 
Rendtorff, R.C., 1954, The experimental transmission of human intestinal protozoan 
parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg 59, 209-220. 
Robertson, L.J., Hanevik, K., Escobedo, A.A., Morch, K., Langeland, N., 2010, 
Giardiasis--why do the symptoms sometimes never stop? Trends Parasitol 26, 
75-82. 
Ropolo, A.S., Saura, A., Carranza, P.G., Lujan, H.D., 2005, Identification of variant-
specific surface proteins in Giardia muris trophozoites. Infect Immun 73, 
5208-5211. 
Roskens, H., Erlandsen, S.L., 2002, Inhibition of in vitro attachment of Giardia 
trophozoites by mucin. J Parasitol 88, 869-873. 
Roxstrom-Lindquist, K., Ringqvist, E., Palm, D., Svard, S., 2005, Giardia lamblia-
induced changes in gene expression in differentiated Caco-2 human intestinal 
epithelial cells. Infect Immun 73, 8204-8208. 
Ruest, N., Couture, Y., Faubert, G.M., Girard, C., 1997, Morphological changes in the 
jejunum of calves naturally infected with Giardia spp. and Cryptosporidium 
spp. Vet Parasitol 69, 177-186. 
Sahagun, J., Clavel, A., Goni, P., Seral, C., Llorente, M.T., Castillo, F.J., Capilla, S., 
Arias, A., Gomez-Lus, R., 2008, Correlation between the presence of 
symptoms and the Giardia duodenalis genotype. Eur J Clin Microbiol Infect 
Dis 27, 81-83. 
Savioli, L., Smith, H., Thompson, A., 2006, Giardia and Cryptosporidium join the 
'Neglected Diseases Initiative'. Trends Parasitol 22, 203-208. 
Scott, K.G., Logan, M.R., Klammer, G.M., Teoh, D.A., Buret, A.G., 2000, Jejunal 
brush border microvillous alterations in Giardia muris-infected mice: role of T 
lymphocytes and interleukin-6. Infect Immun 68, 3412-3418. 
Scott, K.G., Meddings, J.B., Kirk, D.R., Lees-Miller, S.P., Buret, A.G., 2002, 
Intestinal infection with Giardia spp. reduces epithelial barrier function in a 
30	   Chapter 1	  	  
	  
myosin light chain kinase-dependent fashion. Gastroenterology 123, 1179-
1190. 
Scott, K.G., Yu, L.C., Buret, A.G., 2004, Role of CD8+ and CD4+ T lymphocytes in 
jejunal mucosal injury during murine giardiasis. Infect Immun 72, 3536-3542. 
Singer, S.M., Elmendorf, H.G., Conrad, J.T., Nash, T.E., 2001, Biological selection of 
variant-specific surface proteins in Giardia lamblia. J Infect Dis 183, 119-124. 
Singer, S.M., Kamda, J., 2009, Immune Response to Giardia Infection: Lessons from 
Animal Models. Cabi Publishing-C a B Int, Wallingford, 451-462 pp. 
Singer, S.M., Nash, T.E., 2000, T-cell-dependent control of acute Giardia lamblia 
infections in mice. Infect Immun 68, 170-175. 
Skea, D.L., Underdown, B.J., 1991, Acquired resistance to Giardia muris in X-linked 
immunodeficient mice. Infect Immun 59, 1733-1738. 
Snider, D.P., Skea, D., Underdown, B.J., 1988, Chronic giardiasis in B-cell-deficient 
mice expressing the xid gene. Infect Immun 56, 2838-2842. 
Stevens, D.P., Frank, D.M., Mahmoud, A.A., 1978, Thymus dependency of host 
resistance to Giardia muris infection: studies in nude mice. J Immunol 120, 
680-682. 
Stuart, J.M., Orr, H.J., Warburton, F.G., Jeyakanth, S., Pugh, C., Morris, I., Sarangi, 
J., Nichols, G., 2003, Risk factors for sporadic giardiasis: a case-control study 
in southwestern England. Emerg Infect Dis 9, 229-233. 
Svard, S.G., Hagblom, P., Palm, J.E., 2003, Giardia lamblia -- a model organism for 
eukaryotic cell differentiation. FEMS Microbiol Lett 218, 3-7. 
Sweeny, J.P., Robertson, I.D., Ryan, U.M., Jacobson, C., Woodgate, R.G., 2011, 
Comparison of molecular and McMaster microscopy techniques to confirm 
the presence of naturally acquired strongylid nematode infections in sheep. 
Mol Biochem Parasitol 180, 62-67. 
Taminelli, V., Eckert, J., Sydler, T., Gottstein, B., Corboz, L., Hofmann, M., 1989, 
[Experimental infection of calves and sheep with bovine Giardia isolates]. 
Schweiz Arch Tierheilkd 131, 551-564. Tangtrongsup	   S,	   Scorza	  V	   (2010)	  Update	   on	   the	  diagnosis	   and	  management	   of	  Giardia	   spp	   infections	   in	   dogs	   and	   cats.	   Topics	   in	   companion	   animal	  medicine	  25:	  155-­‐162. 
Teoh, D.A., Kamieniecki, D., Pang, G., Buret, A.G., 2000, Giardia lamblia rearranges 
F-actin and alpha-actinin in human colonic and duodenal monolayers and 
reduces transepithelial electrical resistance. J Parasitol 86, 800-806. 
Thompson, R.C., Monis, P.T., 2004, Variation in Giardia: implications for taxonomy 
and epidemiology. Adv Parasitol 58, 69-137. 
Thompson, R.C., Reynoldson, J.A., Mendis, A.H., 1993, Giardia and giardiasis. Adv 
Parasitol 32, 71-160. 
Troeger, H., Epple, H.J., Schneider, T., Wahnschaffe, U., Ullrich, R., Burchard, G.D., 
Jelinek, T., Zeitz, M., Fromm, M., Schulzke, J.D., 2007, Effect of chronic 
Giardia lamblia infection on epithelial transport and barrier function in human 
duodenum. Gut 56, 328-335. 
Tungtrongchitr, A., Sookrung, N., Indrawattana, N., Kwangsi, S., Ongrotchanakun, J., 
Chaicumpa, W., 2010, Giardia intestinalis in Thailand: identification of 
genotypes. J Health Popul Nutr 28, 42-52. 
Upjohn, M., Cobb, C., Monger, J., Geurden, T., Claerebout, E., Fox, M., 2010, 
Prevalence, molecular typing and risk factor analysis for Giardia duodenalis 
infections in dogs in a central London rescue shelter. Vet Parasitol 172, 341-
346. 
Giardia and host responses	   31	  	  
	   	  
Venkatesan, P., Finch, R.G., Wakelin, D., 1996, Comparison of antibody and 
cytokine responses to primary Giardia muris infection in H-2 congenic strains 
of mice. Infect Immun 64, 4525-4533. 
Ventura, L.L., Oliveira, D.R., Viana, J.C., Santos, J.F., Caliari, M.V., Gomes, M.A., 
2013, Impact of protein malnutrition on histological parameters of 
experimentally infected animals with Giardia lamblia. Exp. Parasitol. 133, 
391-395. 
Yanke, S.J., Ceri, H., McAllister, T.A., Morck, D.W., Olson, M.E., 1998, Serum 
immune response to Giardia duodenalis in experimentally infected lambs. Vet 
Parasitol 75, 9-19. 
Younas, M., Shah, S., Talaat, A., 2008, Frequency of Giardia lamblia infection in 
children with recurrent abdominal pain. J Pak Med Assoc 58, 171-174. 
Zenian, A., Gillin, F.D., 1985, Interactions of Giardia lamblia with human intestinal 
mucus: enhancement of trophozoite attachment to glass. J Protozool 32, 664-
668. 
Zhou, P., Li, E., Zhu, N., Robertson, J., Nash, T., Singer, S.M., 2003, Role of 
interleukin-6 in the control of acute and chronic Giardia lamblia infections in 
mice. Infect Immun 71, 1566-1568. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Objectives	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Objectives 35	  	  
	   	  
Objectives 
 
Giardia duodenalis is an omnipresent parasite that infects a wide range of 
vertebrate hosts, including humans. After ingestion, Giardia can cause symptoms 
such as diarrhea or reside in the intestine unnoticed by the host. For a yet unknown 
reason, there exist discrepancies both between and within host species in their ability 
to acquire immunity. Whereas some species, such as rodents and in certain cases also 
humans, are able to eliminate the parasite in a matter of weeks, other host species 
such as cattle develop a chronic infection that can last for several months. A detailed 
analysis of the immunological mechanisms and pathways involved in the immune 
development process in different host species is therefore needed to fully unravel this 
intriguing aspect of Giardia infections in mammals.  
Therefore, the overall objective of this PhD research project was to analyse the 
mechanisms and pathways involved in the intestinal immune responses in two natural 
Giardia-host infection models with different kinetics of immune development, i.e. a 
G. duodenalis infection in cattle that always has a chronic character and a G. muris 
infection in mice that is typically eliminated approximately three weeks post 
infection.  
 
The specific research aims were: 
1) To unravel the immunological responses in the intestine of calves infected 
with G. duodenalis during the acute phase of the infection, i.e. three weeks 
post infection, through a genome-wide transcriptome analysis combined 
with histology (results described in Chapter 2). 
2)  To analyze and monitor the kinetics of the protective intestinal immune 
response in mice following a G. muris infection again for 3 weeks of 
infection with a particular focus on cytokine transcription patterns and 
histology (results described in Chapters 3 & 4) 
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2.1. Introduction 
 
The clinical manifestation of a G. duodenalis infection ranges from an 
asymptomatic carrier state to gastro-intestinal complaints such as diarrhea, weakness, 
weight loss, abdominal pain and possibly nausea, vomiting, flatulence and fever. 
Although in many cases the infection is acute and self-limiting, a significant 
proportion of humans will develop a chronic infection with intermittent diarrhea and 
cyst excretions lasting for several weeks or even months (Rendtorff, 1954; Robertson 
et al., 2010). In cattle, infections will always be of a chronic nature. Finding the 
answer as to why exactly some infections remain chronic is hindered by our limited 
knowledge on the in vivo immune response in these animals. For now, this knowledge 
is limited to a number of studies in which antibody levels were measured in serum 
and milk (O'Handley et al., 2003; Yanke et al., 1998).  
So despite the importance of the parasite in cattle, there is little information 
available on the intestinal host-parasite interactions in these animals. Therefore, the 
objective of this chapter was to investigate the intestinal response in calves following 
a primary G. duodenalis infection. The chosen approach involved the use of a 
microarray and quantitative real-time PCR (qRT-PCR) to obtain a gene transcription 
profile in infected animals combined with histological work. 
 
 
2.2. Material and methods 
 
2.2.1. Infection trial and tissue collection.  
 
This study was conducted in accordance with the E.U. Animal Welfare 
Directives and VICH Guidelines for Good Clinical Practice, and ethical approval to 
conduct this study was obtained from the Ethical Committee of the Faculty of 
Veterinary Medicine, Ghent University.  
Eight male Holstein calves, two to four weeks old, were used for the trial. 
Prior to arrival, all animals were screened three consecutive days for the presence of 
Giardia cysts and Cryptosporidium oocysts in their faecal samples with the use of the 
commercially available MERIFLUOR Cryptosporidium/Giardia immuno-
fluorescence assay (IFA) (Meridian diagnostics Inc., Cincinnati, OH). In addition, the 
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animals were checked for the presence of Bovine Viral Diarrhea antigen in their 
blood, while faecal samples were screened for the presence of Eimeria spp. oocysts 
(McMaster method). After confirming their negative status for all these pathogens, 
four randomly chosen animals were placed in a pen in which Giardia-excreting calves 
had been housed prior to this experiment. The four remaining animals were kept as 
negative controls in separate G. duodenalis-free stables. All calves in the study 
received the same commercial milk replacer (Spraystart-Z® from Aveve; 6L per 
calf/day). Water and hay were provided ad libitum throughout the experiment. After 
three weeks, the presence or absence of a G. duodenalis infection was confirmed by 
IFA in faecal samples from all calves after which the animals were euthanized.   
Jejunal tissue samples for gene expression analysis and histology were taken 3 
meters from the pylorus. For RNA extraction, tissue was immediately snap frozen in 
liquid nitrogen and stored at -80°C. The same procedure was followed for the 
draining mesenterial lymph nodes. For histological purposes, tissue was fixed in 10% 
formaldehyde in phosphate buffered saline (PBS) for 24h, followed by incubation for 
1h in distilled water and storage in 70% ethanol, all at room temperature. The samples 
were subsequently dehydrated through a series of graded ethanol solutions followed 
by xylene and embedded in paraffin.  
 
2.2.2. Molecular characterization.  
 
Faecal samples were collected in order to genotype G. duodenalis present in 
the infected animals. The necessary DNA was extracted using the QIAamp Stool Mini 
Kit (Qiagen) according to the manufacturer’s instructions, incorporating an initial step 
of three freeze–thaw cycles (freezing in liquid nitrogen for 5 min and heating at 95°C 
for 5 min) into the protocol to maximize cyst lysing. The eluted DNA was dissolved 
in 15 µl of ultra-pure water.  
A nested PCR targeting the triosephosphate isomerase (tpi) gene was used for specific 
amplification of assemblage A and E, as described by Geurden et al. (Geurden et al., 
2008).  
 
2.2.3. RNA extraction.  
 
Extraction of total RNA from tissue samples was done using TRIzol 
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(Invitrogen) followed by further purification with the RNeasy Mini kit (Qiagen) 
following the manufacturer’s instructions. An on-column DNase digestion was 
performed using the RNase-free DNase set (Qiagen) to remove any contaminating 
genomic DNA. Total RNA concentrations were determined using a NanoDrop ND-
1000 spectrophotometer (NanoDrop Technologies) and the quality of the RNA was 
verified with an ExperionTM Automated Electrophoresis System (Bio-Rad).  For all 
samples, the RNA quality indicator (RQI) calculated by the Experion™ software 
(Bio-Rad) was >8.0, indicating high RNA integrity.  
 
2.2.4. Microarray analysis and Ingenuity Pathway Analysis.  
 
The RNA extracted from the jejunum of all the animals was used for microarray 
analysis.  Double-stranded cDNA was synthesized using the SuperscriptTM Double-
Stranded cDNA Synthesis kit (Invitrogen) followed by further concentration using the 
DNA Clean and ConcentratorTM-25 (Zymo Research) following manufacturer’s 
instructions. Microarray (Roche Nimblegen, Inc., Madison, WI) design and 
hybridization procedures were performed as previously described (Li and Li, 2006). 
The bovine microarray consisted of 86,191 unique 60mer oligonucleotides, which 
represents 45,383 bovine sequences or genes. Each unique oligonucleotide was 
repeated four times on the microarray. After hybridization, scanning and image 
acquisition, data extraction from the raw images was executed using NimbleScan 
software (NimbleGen, Madison, WI). For each feature, relative signal intensities 
(log2) were generated using the robust multi-array average algorithm (Irizarry et al., 
2003). Further processing of the data was done based on the quantile normalization 
method (Bolstad et al., 2003). The background-adjusted, normalized and log-
transformed intensity values were further analyzed using MeV v4.2 
(http://www.tm4.org/mev/). Raw and processed microarray data were deposited to the 
NCBI Gene Expression Omnibus (GEO) database (Accession# GSE35920). 
The Ingenuity Pathway Analysis (IPA) software V6.0 (Ingenuity® Systems, 
www.ingenuity.com) was used to organize the genes regulated during the infection 
into networks of interacting molecules. The gene identifiers of the genes with a 
statistically significant change in expression (p < 0.01 and p < 0.05) and with a 
calculated positive or negative fold change of at least two-folds were uploaded in the 
software. These genes, called focus genes, were overlaid onto a global molecular 
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network developed from information contained in Ingenuity’s Knowledge Base. 
Networks were then algorithmically generated based on their connectivity. Each 
network is assigned a score, a numerical value that ranks the networks according to 
how relevant they are to the genes in the uploaded dataset based on the number of 
focus genes and the size of the network. In addition, IPA was used for a functional 
analysis to identify the biological functions that were most significant to the uploaded 
datasets. Right tailed Fisher’s exact test was used to calculate a p-value determining 
the probability that each biological function assigned to that dataset is due to chance 
alone. The same method is used to analyze the biological functions of a calculated 
network. 
 
2.2.5. Quantitative Real-time PCR.  
 
A qRT-PCR approach was used to validate the generated microarray data. The 
gene expression data of five upregulated and two downregulated genes were used as 
endogenous controls and analyzed with qRT-PCR. These genes include ATP-binding 
cassette sub-family G (WHITE) member 8 (ABCG8), adenosine deaminase (ADA), 
fatty acid synthase (FASN), peroxisome proliferator-activated receptor alpha 
(PPARα), peroxisome proliferator-activated receptor gamma (PPARγ), RAS guanyl 
releasing protein 2 (RASGRP2) and ras homolog gene family, member D (RHOD). In 
addition, qRT-PCR was also used to further elucidate the host-response during 
infection by analyzing expression of genes coding for the following cytokines: INF-γ, 
IL-1β, IL-4, IL-6, IL-8, IL-10, IL-13, IL-17, TGF-β1 and TNF-α. 
The qRT-PCR analyses were performed using the SYBR Green Master Mix 
(Applied Biosystems) on cDNA samples produced using the iScript cDNA synthesis 
kit following the manufacturer’s instructions.  Two µl of single stranded cDNA (10 
ng of the input total RNA equivalent) and 500 nM of amplification primer were used 
in a reaction volume of 20 µl. The primer sets used to amplify the different bovine 
genes were designed using Primer3 software (http://frodo.wi.mit.edu/primer3/) and 
are listed in the appendix.  
A StepOnePlus Real-Time PCR system (Applied Biosciences) executed the 
amplification cycles as follows: 95°C for 20 s; 35 cycles of 95°C for 5 s; and optimal 
annealing temperature (Ta) for 30 s. For all genes tested, the Ta was set at 60°C, with 
the exception of IL-4 where the Ta was 64°C. Reaction efficiencies were measured 
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based on a standard dilution curve obtained by serial dilutions of pooled cDNA 
material from all the samples. To ensure specificity of the primers, melting curve 
analyses were performed at the end of the reactions, and the obtained PCR products 
were sequenced. In every assay, cDNA samples were analyzed in duplicate, and a 
non-template control was added. The obtained Ct values were transformed in relative 
quantities using the delta Ct method, which applies following formula: Q=E(min Ct-
sampleCt). In this formula, Q represents the relative quantity for each sample, E the 
amplification efficiency of the run, min Ct is the lowest Ct value among all the 
samples for each gene analyzed and sampleCt is the Ct for each sample in the run 
(http://medgen.ugent.be/∼jvdesomp/genorm/geNorm_manual.pdf). These quantities 
were normalized against internal control genes, referred to as housekeeping genes 
(HKGs). The correct HKG were selected out of a panel of 6 candidate genes (beta 
actin (ACTB), hypoxanthine phosphoribosyltransferase 1 (HPRT1), ribosomal protein 
P0 (RPLP0), succinate dehydrogenase flavoprotein subunit A (SDHA), TATA box 
binding protein (TBP)-associated factor (TAF2), and ubiquitin-conjugating enzyme 
E2D2 (UBE2D2) based on the gene stability measure M calculated by the GeNorm 
(geNorm3.5) software using the developers recommendations (Andersen et al., 2004). 
This identified UBE202 and ACTB as the most suitable HKG for jejunal samples and 
RPLP0 and HPRT1 for tissue of mesenterial lymph nodes. 
Statistical analysis was carried out using GraphPad Prism software. The 
Nonparametic Whitney U test was used to determine differences between the infected 
and the control group. A P-value ≤ 0.05 was considered significant.  
 
2.2.6. Histology.  
 
Jejunal tissue sections of 4 µm were cut and mounted on APES-coated glass 
slides. Immunohistochemical stainings with a polyclonal rabbit anti-human CD3 
(Dakocytomatio A/S, Glosturp, Denmark), a rabbit anti-human CD-20 (Neomarkers, 
CA, USA), and a monoclonal mouse anti-human MAC387 (Serotec, Cergy Saint-
Christophe, France) were performed to identify and count T-cells, B-cells and 
macrophages, respectively, as previously described by Vangeel et al. (2011) (Vangeel 
et al., 2012). Briefly, this included the use of the peroxidase streptavidin complex 
(Dakocytomatio A/S, Glosturp, Denmark), diaminobenzidin tetrahydrochloride 
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(DAB, Sigma-Aldrich, St. Louis, USA), and H2O2 followed by counterstaining with 
haematoxylin. Quantification was done by counting positive cells in the lamina 
propria of a villus and associated crypt with light microscopy (Olympus BS 61, 
Olympus Belgium, Aartselaar, Belgium), via a 40x objective (400x magnification). 
Five appropriate areas were chosen randomly on each slide and cells were expressed 
as number of cells per 105µm2. Intraepithelial lymphocytes (IEL) were calculated by 
counting the number of CD3 positive lymphocytes per 100 enterocytes along the 
villus at 400x magnification. For this, at least 500 enterocytes were counted per 
sample.  
To quantify the number of eosinophils and mast cells in the jejunal mucosa, 
tissue sections were stained with haematoxylin-eosin (HE) and Giemsa, respectively. 
For each cell type, 10 non-overlapping high power fields (HPF) (400x) were checked 
and numbers were summed up to give a total cell count per 10HPF.  
To quantify apoptosis, apoptotic cells were counted using fluorescence 
microscopy (400x) on tissue slides (4µm) stained with the DeadEndTM Fluorometric 
TUNEL system (Promega). Staining was performed following the manufacturer’s 
recommendations. Counterstaining of the nuclei was done using DAPI (4’, 6-
diamidino-2-phenylindole, dilactate; 1:1000 in PBS; Invitrogen) for 5 minutes at 
room temperature.  Five appropriate areas were chosen randomly on each slide, and 
apoptotic cells were expressed as number of cells per 105µm2. 
Finally, the length of the villi and depth of the crypts in the jejunum were 
measured by analyzing 15 villi and their corresponding crypts under a microscope 
using a calibrated micrometer at 200x magnification. All results were compared by 
the student’s t-test using GraphPad Prism software. A P-value ≤ 0.05 was considered 
significant.   
 
 
2.3. Results 
 
2.3.1. Infection trial.  
 
After 3 weeks of environmental exposure to G. duodenalis cysts, all four 
animals in the infected group tested positive for Giardia cysts in their faeces. Mean 
cyst excretion varied between 3950 and 15,000 cysts per gram (CPG) of faeces with 
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an average of 10,328 CPG. Genotyping of the collected cysts revealed that animals 
were infected with the livestock-specific G. duodenalis assemblage E. The control 
group remained negative throughout the study.  
 
2.3.2.  Transcriptomic profiles and pathway analysis.  
 
A bovine high-density oligo microarray was used to analyze global gene 
expression in the small intestine of the calves. At a 95% confidence level (P< 0.05), 
140 genes were differentially expressed after infection with a minimum two-fold 
change (see appendix), 57 genes were transcriptionally downregulated, and 83 genes 
were upregulated.  
Up-or down-regulation of 7 selected genes which showed the highest fold 
changes according to the microarray data were subsequently verified by quantitative 
PCR. Consistent with the microarray results, the expression of PPARα and PPARγ, 
ATP-binding cassette transporter (ABCG8), adenosine deaminase (ADA), and Ras 
homolog gene family member D (RHOD) was upregulated in the infected animals 
compared to controls, while a downregulation was confirmed for Ras guanyl releasing 
protein 2 (RASGRP2) and fatty acid synthase (FASN) (Figure 2.1); however, the 
downregulation of RASGRP2 as measured by qRT-PCR was not significant.  
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Figure 2.1. qRT-PCR validation of selected differentially expressed genes 
identified by microarray. Quantitative PCR on a panel of 7 genes was used to verify 
the up-or-down regulation observed by microarray analysis. Consistent with the 
microarray results, expression of PPARA, RHOD, ABCG8, PPARG and ADA was 
upregulated when comparing infected animals to controls, while a downregulation 
could be seen for RASGRP2 (although not significant) and FASN. (* P < 0.05). 
 
The IPA software was subsequently used to further examine the microarray 
dataset. When the dataset was uploaded, IPA determined the biological functions 
related to this dataset and gave the predicted activity of these functions. Overall, 4 
main categories of functions were associated with the uploaded dataset: migration of 
leukocytes, inflammation, immune response, and lipid metabolism (summarized in 
Table 2.1.). A total of 19 genes were related with cellular migration of B-cells, T-
cells, phagocytes, and granulocytes, a function for which IPA predicted decreased 
activity. Two other functions impacted by the infection are part of the lipid 
metabolism. These include a decrease in lipid quantity (10 genes involved) as well as 
a decreased production of eicosanoids (5 genes involved). Finally, two functions 
labeled as ‘immune response’ and ‘inflammation’ both had a predicted decreased 
activity, with involvement of respectively 19 and 11 genes. The analysis also 
indicated that 4 genes were involved in all of the impacted functions, i.e. ADA, NOS2 
(nitric oxide synthase 2), PPARα, and PPARγ. 
Three networks were calculated by IPA based on the uploaded p<0.05 dataset 
with a score higher than 20, implying that there is a probability of 10-20 that the genes 
in this network are solely associated by chance. The highest scoring network (score of 
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39) again deals with immune cell trafficking with a central role for the PPAR genes 
(Figure 2.2, panel A). Network 2 had a score of 25 and is associated with tissue 
morphology, cellular growth/proliferation, and cellular development. Finally, the 
network functions of the third network (score of 23) included lipid metabolism, 
molecular transport, and small molecule biochemistry.  
 
Table 2.1. Impacted biological functions and associated genes during Giardia 
duodenalis infection in calves as calculated by IPA. 
Function Prediction by 
IPA 
Genes involved 
upregulated 
Genes involved 
downregulated 
Inflammatory 
response 
Decreased ADA, NT5E, PPARA, 
PPARG,  
NOS2, IL12RB1, 
CXCL13,  
  CCL14, PLA2G1B, FGG DEFB4A 
Immune response Decreased ADA, NT5E, PPARA, 
PPARG,  
HSPH1, 
MADCAM1, 
IL12RB1,  
  PLA2G1B, CCL14, FGG, CXCL13, 
DEFB4A, 
CD79B, 
  PLXNA1 ITGA4, CD1B, 
NOS2, MS4A1, 
   POU2AF1 
Migration of 
leukocytes 
Decreased ADA, NT5E, PPARA, 
PPARG,  
MADCAM1, 
NOS2, IL12RB1,  
  PLA2G1B, CCL14, ALB CXCL13, 
RASGRP2, 
SH2D3C, 
   F13A1, ITGA4, 
CXCR5, 
   DEFB4A, 
POU2AF1, 
MAP4K1 
Quantity of lipid Decreased AQP7, ADA, PPARA, 
HPGD,  
NOS2 
  PLA2G1B, ALB, PPARG,  
  LRAT, ABCG8  
Production of 
eicosanoid  
Decreased HPGD, PLA2G1B NOS2, FASN, 
DEFB4 
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Figure 2.2. Regulatory networks impacted in the jejunum of Giardia duodenalis 
infected calves.  
(A) Score of 39. The network functions include immune cell trafficking and cell 
movement. (B) Score of 25. Functions include tissue morphology, cellular 
development, cellular growth and proliferation. (C) Score of 23. Functions include 
lipid metabolism, molecular transport and small molecule biochemistry. Color code: 
red, upregulated gene; green, downregulated gene. The degree of up- or 
downregulation is represented by the intensity of the colors, ranging from 2-fold to 
20-foldchange.  
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2.3.3. Analysis of the intestinal immune response.  
 
Since the microarray data suggested a lack of inflammation, immune response 
and immune cell migration, the intestinal immune responses in the animals were 
investigated in more detail by analyzing cytokine transcription levels combined with 
histological analyses, such as immune cell counts, quantification of apoptosis, and 
villus/crypt measurements. The results of the qRT-PCRs on a selected panel of 
cytokines are shown in Figure 2.3 as mean fold changes in infected animals compared 
to the control animals. In jejunal tissue, no significant differences in transcription 
levels were found for IFN-γ, IL-4, IL-6, IL-8, IL-10, TGF-β1, and TNF-α. The 
expression of IL-13, IL-17, and IL-1β was significantly downregulated with a fold 
change of 0.43, 0.06, and 0.59 respectively. There was no significant alteration of 
cytokine expression in the mesenteric draining lymph nodes of infected animals 
versus those of control animals.  
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Figure 2.3. Cytokine expression profiles in jejunum and mesenterial lymph nodes of 
Giardia duodenalis infected calves. Transcription levels of the main cytokines were analyzed 
using quantitative PCR. Mean fold changes (n = 4) when comparing infected animals to 
controls are presented with SEM as error bars. In jejunal tissue (panel A), no significant 
differences in transcription levels were found for INF-γ, IL-4, IL-6, IL-8, IL-10, TGF-β1 and 
TNF-α. The transcription of IL-13, IL-17, and IL-1β was significantly downregulated. In the 
draining mesenteric lymph nodes (panel B), there was no significant alternation of cytokine 
transcription. (* P < 0.05). 
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Upon histological examination of the samples, the general morphology of the 
jejunal mucosa appeared to be normal without signs of inflammation. The results of 
the cell counts and villus/crypt measurements are summarized in Table 2.2 and 2.3. 
No significant differences were observed for T cells, B cells, mast cells, eosinophils, 
or the number of apoptotic cells between infected and control animals. Only the 
number of macrophages was significantly lower in infected animals (2.17 per 105µm) 
than in controls (3.17 per 105µm). A significant difference was also found for the 
villus/crypt ratio with an increased ratio in the infected animals (p < 0.05).  
 
Table 2.2. Histological cell counts in jejunal tissue of control animals and Giardia 
duodenalis infected calves. 
 IELa T-cells b 
(CD3+) 
B-cells b 
(CD20+) 
Macrophagesb 
(MAC387+) 
Eosinophilsc Mast 
cellsc 
Control 23.2 ± 4.1 240 ± 37.5 2.6 ± 1.3 3.2 ± 0.6 549 ± 295 23 ± 19 
Infected  18.7 ± 3.1 217 ± 23.1 4.7 ± 2.7 2.2 ± 0.2* 348 ± 128 43 ± 40 
a intraepithelial lymphocytes per 100 enterocytes  
b number of cells per 105µm2 
 c number of cells per 10HPF 
*P ≤ 0.05 versus control group, data are mean ± SEM 
 
Table 2.3. Villus and crypt measurements in jejunal tissue of control animals and 
Giardia duodenalis infected calves. 
 Villus length (µm) Crypt depth (µm) Villus/crypt ratio 
 Mean ± sd Range Mean ± sd Range Mean ± sd Range 
Control 378 ± 27 313-447 237 ± 27 203-337 1.45 ± 0.11 1.26-1.68 
Infected 506 ±47 385-584 253 ± 23 201-308 2.17 ± 0.15* 1.91-2.59 
* P ≤ 0.05 versus control group 
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2.4. Discussion 
 
In this study, gene transcription in the jejunum of uninfected and primary 
infected calves was analyzed using a whole genome microarray to increase our 
knowledge on host-parasite interactions in natural hosts, more specifically in cattle.  
This generated a list of functions and networks in IPA of which some can be related to 
suppression of inflammation and immunity. Further qRT-PCR analysis of a selected 
panel of cytokines revealed a trend of downregulated expression in infected animals 
compared to the negative controls. In addition, no immune cell recruitment was 
detected in the intestine of the infected calves. 
Microarray analyses identified the activation of PPARα and PPARγ as the 
possible regulators of the observed host responses. These nuclear receptors can be 
expressed in epithelial and endothelial cells as well as in immune cells such as T cells, 
B cells, dendritic cells, and macrophages (Straus and Glass, 2007). The PPARs belong 
to the subfamily of the nuclear receptors, which also includes the receptors for 
retinoic acid, vitamin D and others. Similar as these receptors, the PPARs consist of 5 
distinct regions, from which the DNA-binding domain (DBD) and the ligand-binding 
domain (LBD) are the most conserved. Usually PPAR activation occurs when an 
agonist binds the LBD. To modulate DNA transcription, the PPARs need to bind to 
nucleotide sequences, called PPAR response elements (PPRE), which are located in 
the regulatory regions of their target genes. To complete the DNA binding and 
interact with the PPRE, it is necessary for the PPARs to form a heterodimer with a 9-
cis-retinoic acid receptor (RXR). Ligand binding to PPARα induces conformational 
changes in the PPAR-RXR complex that allow the receptors to dissociate from co-
repressor complexes and associate with co-activators. These co-activators rearrange 
chromatin packaging so that the transcriptional machinery has access to the promoter 
region of the target gene (Contreras et al., 2013; Daynes and Jones, 2002; Straus and 
Glass, 2007). The activation of PPARs can exert an anti-inflammatory effect by 
transrepressing the activity of several transcription factors, such as nuclear factor-κB 
(NF-κB) and activator protein 1 (AP1) (Daynes and Jones, 2002). Through this 
transrepression, the release of pro-inflammatory cytokines (IL-6, TNF-α, IL-12, IL-
17, and IL-1β) and iNOS can be inhibited, as well as the recruitment of leukocytes 
(Glass and Ogawa, 2006; Straus and Glass, 2007). Whether the PPAR activation 
actually leads to the negative modulation of the inflammatory and immune response 
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observed in the Giardia infected calves is still unclear. Further studies using PPAR 
agonists and antagonist are needed to provide direct evidence of the biological role of 
these receptors in the host response. Interestingly, the up-regulation of PPARγ was 
also observed in Caco-2 human intestinal epithelial cells after being incubated with G. 
duodenalis trophozoites for 18 hours (Roxstrom-Lindquist et al., 2005). 
How exactly PPAR activation occurs during the Giardia infection in these 
calves is unclear. The endogenous ligands of the PPARs are various fatty acids and 
metabolites of fatty acid metabolism that can be produced by inflammatory responses 
(Daynes and Jones, 2002). The ability to induce activation of PPARs was seen in 
other parasite infections such as Plasmodium spp., Toxoplasma gondii, and protozoa 
of the Leishmania genus. Plasmodium spp. rupture red blood cells they infect. This 
leads to the formation of hemozoin, in its turn causing the release of the PPARγ 
ligand 15-hydroxyeicosatetraenoic acid (15-HETE). Toxoplasma gondii induces the 
production of PPAR ligands by platelets, while visceral Leishmania infection induced 
PPARγ expression on residual macrophages, liver and spleen of mice (Chan et al., 
2010). Sphingolipids could be the responsible activators of the PPARs during a 
Giardia infection. These lipids have shown to be possible ligands for PPARs (Tsuji et 
al., 2009) and are also produced de novo by this parasite (Zhang et al., 2010). 
Besides the PPARs, other genes could be involved in the observed immune 
suppression, as function analysis by IPA indicated. An example is ADA, a gene 
coding for adenosine deaminase that is upregulated in the infected animals. This 
enzyme is involved in the deamination of adenosine, a purine that can exert several 
effects on inflammation, both pro- and anti-inflammatory (Blackburn et al., 2009). 
The end product of adenosine deamination is inosine, which in itself also has an anti-
inflammatory effect (Hasko et al., 2004).  
Furthermore, no intestinal pathologies, such as villus shortening or increased levels of 
apoptosis were observed in the intestines of infected animals. The available 
information on pathophysiological changes induced by a Giardia infection in humans 
and animals is often contradictory. While some studies report histological changes in 
the villi and crypts and increased levels of intraepithelial lymphocytes in infected 
hosts (Cotton et al., 2011; Ruest et al., 1997), others describe the lack of inflammation 
or other typical histological features in the majority of the patients investigated 
(Oberhuber et al., 1997). The reason for this discrepancy is still unclear, although 
some authors have suggested that assemblage-specific differences might exist. In a 
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study by Chin et al. (2002) (Chin et al., 2002), the ability of G. duodenalis to induce 
apoptosis in enterocytes appeared to be strain dependent. In humans, patients infected 
with assemblage A are more likely to present clinical signs than those infected with 
assemblage B, although once established infections with assemblage B seem to result 
in more persistent diarrhea (Homan and Mank, 2001; Read et al., 2002). Whether the 
general absence of pathologies or immune response in the current experiment was due 
to the infection with assemblage E needs to be further studied. Interestingly, Barigye 
et al. (2008) (Barigye et al., 2008) previously described the absence of histological 
changes in the intestines of four out of five calves infected with assemblage E, 
supporting the observations made in this study. Alternatively, the presence or absence 
of inflammation, histological damage and/or clinical signs may depend on the 
infection dose. In this experiment, calves that were introduced into a contaminated 
housing excreted between 3950 and 15,000 CPG. While similar infection levels are 
often observed in field conditions, naturally infected calves can excrete up to 106 CPG 
(Geurden et al., 2004; Xiao et al., 1996).  
Apart from the apparent immunosuppressive pathway induced by the Giardia 
infection, several genes involved in lipid metabolism were also impacted, such as 
genes coding for enzymes involved in lipid synthesis or lipolysis (PLA2G1B, 
CYP3A5, HPGD, ADA), transcription factors regulating the lipid metabolism 
(PPARα, PPARγ), and the ABC transporter ABCG8, responsible for efflux of 
cholesterol from enterocytes into the intestinal lumen or as high-density lipoproteins 
in plasma. Theoretically, the observed transcriptional changes would lead to a 
decreased uptake of lipids in the intestine and a higher efflux of cholesterol in the 
intestinal lumen. This host response could actually be beneficial for the parasite, since 
several studies have previously shown that some protozoa, including Giardia, are 
unable to synthesize the majority of their lipids and cholesterol de novo and rely on 
the host’s intestinal milieu for these products (Das et al., 2002). Interestingly, it has 
been reported that Giardia-infected human patients often show intestinal fat 
malabsorption (Katelaris et al., 1991) and significantly lower levels of total serum 
cholesterol compared to healthy controls (Bansal et al., 2005). Whether this is the 
result of a similar intestinal response in humans as observed in cattle still needs to be 
further examined.  
In conclusion, the outcome of the current study suggests that a primary G. 
duodenalis assemblage E infection in calves results in a lack of inflammation, 
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immune response and immune cell migration in the infected animals. This could 
explain the often chronic nature of a G. duodenalis infection in cattle and the lack of 
inflammation in the intestinal tissue. Whether G. duodenalis infections in other host 
species or G. duodenalis assemblage A infections in calves induce a similar intestinal 
response is still unclear and requires further research.  
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3.1. Introduction 
 
In chapter 2, the intestinal host response in calves infected with the ruminant-
specific G. duodenalis assemblage E was investigated. Using a bovine high-density 
microarray to analyse global gene transcription combined with histological work, the 
acute phase of the infection in cattle was marked by a lack of inflammation and 
immune cell infiltration.  
In this chapter the objective was to gather further insights in the intestinal host 
response by using a murine giardiosis model where mice are infected with their 
natural parasite G. muris. The life cycle and infection process of this parasite is 
basically identical to that of G. duodenalis, with the only difference being that most 
mice strains are able to clear a G. muris infection after 3 to 6 weeks of contact with 
the parasite (Roberts-Thomson and Mitchell, 1978). Regarding the development of 
immunity against G. muris, earlier work already indicated the importance of CD4+ T 
cells (Heyworth et al., 1987; Stevens et al., 1978), B cells (Skea and Underdown, 
1991; Snider et al., 1988) as well as IgG and IgA antibody production (Daniels and 
Belosevic, 1994; Heyworth, 1986). Work done on the mucosal inflammatory response 
in G. muris infected mice also suggested mast cells, mucus production and IFN-γ as 
possible elements in the host response (Venkatesan et al., 1997). However, further 
information regarding the type of immune response (Th1-Th2-Th17), regulatory 
pathways and effector mechanisms involved and, finally, the dynamics of the whole 
immune development process is still missing. Therefore in this chapter the cytokine 
transcription patterns in the intestinal tissue at different time-points following a G. 
muris infection were analyzed in BALB/C and C57Bl/6 mice, two mouse strains 
known to develop immunity against this parasite.  
 
3.2. Material and methods 
 
3.2.1. Ethical statement. 
 
This study was conducted in accordance with the E.U. Animal Welfare 
Directives and VICH Guidelines for Good Clinical Practice. Ethical approval was 
obtained from the Ethical Committee of the Faculty of Veterinary Medicine, Ghent 
University.  
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3.2.2.  Infection studies.  
 
In each experiment, mice were infected orally with 103 G. muris cysts 
suspended in 0.2 ml phosphate buffered saline. Giardia muris cysts were obtained 
from Prof Dr M. Belosevic, University of Alberta, Edmonton, Canada. The different 
infection trials are summarized in table 3.1. 
In a first infection experiment, female BALB/c animals of 6 weeks old (Harlan 
laboratories) and the appropriate negative controls (all groups: n= 5) were used. Cyst 
counts were monitored daily to analyze the infection pattern and intestinal samples 
were taken from the control animals and the infected animals at week 1, 2 and 3 pi (n 
= 5 at each time point).  
Infection experiment 2 consisted of infected female C57Bl/6 animals (Harlan 
laboratories) and the appropriate negative controls (all groups: n= 5). All animals 
were 6 weeks old at time of infection. In this trial, cyst counts were performed daily 
and intestinal samples were taken from the control mice and the infected animals at 
week 1, 2 and 3 pi (n = 5 at each time point).  
 For infection experiment 3, female IL-17 receptor A KO (Flierl et al., 2008) 
mice were used. This mouse line has been crossed back into a C57BL/6J background 
for over five generations. These animals (n = 5) were infected for 3 weeks where cyst 
counts were counted daily and compared to the appropriate C57Bl/6 WT controls 
(n=5).  
Infection experiment 4 used infected female C57Bl/6 animals. Starting day 1 
pi, 5 animals were necropsied daily until day 7 for intestinal samples. Every day, 2 
negative controls were necropsied and pooled as one group at the end of the trial.  
   
3.2.3. Cyst counts.  
 
To monitor the course of a G. muris infection, cyst excretion in faeces was 
measured as described previously by Roberts-Thomson et al. (1978). In summary, 
faeces were collected from each mouse individually over a 2 h period and weighed. 
Next, the stool was homogenized with PBS and centrifuged at low speed (800g, 
15min) over a 1M sucrose gradient. The obtained cysts in the top layer were further 
washed, resuspended in 1 ml of PBS and counted in a hemacytometer. Cyst excretion 
was then expressed as number of cysts per gram faeces.  
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Table 3.1. Summary of mice experiments 
Expt 
nb 
Objective Strain 
 
Age 
(w) 
Sex Trial 
duration 
Number 
of 
animals 
Time point 
of 
sampling 
pi1 
Analyzed 
data2 
1 Intestinal 
immune 
response 
BALB/c 6  F 3 weeks 15 
infected  
5 negative 
controls 
Week 1 
Week 2 
Week 3 
Cyst 
excretion 
Intestinal 
cytokine 
levels 
2 Intestinal 
immune 
response 
C57Bl/6 6  F 3 weeks 15 
infected  
5 negative 
controls 
Week 1 
Week 2 
Week 3 
Cyst 
excretion 
Intestinal 
cytokine 
levels 
3 Effect of 
IL17A on 
intestinal 
immune 
response 
C57Bl/6 
IL17RA-
KO 
6  F 3 weeks 5 infected 
IL17RA 
KO mice  
5 infected 
controls 
NA Cyst 
excretion 
 
4 Early 
intestinal 
immune 
response 
C57Bl/6 6  F 1 week 35 
infected  
14 
negative 
controls 
Daily, 
starting day 
1 pi until 
day 7 
Intestinal 
cytokine 
levels 
1 samples were taken from the small intestine for subsequent qRT-PCR analysis of the main 
cytokines. 2 cyst counts in faeces were performed daily for each animal  
 
3.2.4. Tissue sample collection.  
 
At necropsy, 1 cm long fragments of the small intestine were taken from each 
animal starting 4 cm from the gastro-duodenal junction. To allow RNA extraction, the 
intestinal tissue was snap frozen in liquid nitrogen and stored at -80°C.  
 
3.2.5. RNA isolation and quantitative real time PCR.  
 
Total RNA was isolated by adding TRIzol (Invitrogen) to tissue followed by 
an RNA purification with the RNeasy mini kit (Qiagen). Any contaminating genomic 
DNA was removed with the help of the RNase-free DNase set (Qiagen) for on-
column DNase digestion. An ExperionTM Automated Electrophoresis System (Bio-
Rad) was used to verify the quality of the isolated RNA, while total RNA 
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concentrations were determined using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies). To obtain the cDNA samples needed for quantitative Real-
time PCR (qRT-PCR) the iScript cDNA synthesis kit was used following the 
manufacturer’s instructions.  
All qRT-PCR analyses were carried out using the SYBR Green Master Mix 
(Applied Biosystems), with 2 µl of single stranded cDNA (10 ng of the input total 
RNA equivalent) and 500 nM of amplification primer in a reaction volume of 20µl. 
The primer sets for amplification of the different genes were designed using Primer3 
software (http://frodo.wi.mit.edu/primer3/) and are listed in the appendix.  
All analyses were run on a StepOnePlus Real-Time PCR system (Applied 
Biosciences) with the following amplification cycles: 95°C for 20 s; 35 cycles of 
95°C for 5 s and 60°C (optimal annealing temperature for all the examined genes) for 
30 s. Reaction efficiencies were measured based on a standard dilution curve obtained 
by serial dilutions of pooled cDNA material from all the samples. In every assay, a 
non-template control was added and cDNA samples were analyzed in duplicate. At 
the end of the reactions melting curve analyses were performed to ensure specificity 
of the primers. The delta Ct method was applied to transform the obtained Ct values 
in relative quantities. With this method, the following formula was used: Q=E(min Ct-
sampleCt) where Q represents sample quantity relative to the sample with highest 
transcription; E represents amplification efficiency; min Ct is equal to the lowest Ct 
value; and sampleCt is the Ct value of sample with the highest transcription level. The 
obtained quantities were then normalized against internal control genes, referred to as 
housekeeping genes (HKGs). Out of a panel of 6 candidate genes (beta actin (Actb), 
hypoxanthine phosphoribosyltransferase 1 (Hprt1), ribosomal protein P0 (Rplpo), 
succinate dehydrogenase flavoprotein subunit A (Sdha), TATA box binding protein 
(TBP)-associated factor (Taf2), and ubiquitin-conjugating enzyme E2D2 (Ube2d2)) 
the most stable HKGs were selected based on the gene stability measure M calculated 
by the GeNorm software (geNorm3.5) (Andersen et al., 2004). The eventual gene 
expression normalization factor for each animal sample was calculated based on the 
geometric mean of the two selected HKG’s.  For the BALB/c animals, Hprt1 and 
Rplpo appeared to be the most suitable HKG. In C57Bl/6 animals, this resulted in the 
use of Hprt1 and Tbp. Gene expression was evaluated based on fold differences in 
gene transcription levels compared to the negative control animals. This was done by 
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calculating the ratios of individual relative quantities on the geometric means of 
relative values of the control samples. 
Statistical analysis was carried out using GraphPad Prism software. A one way 
ANOVA followed by a Dunn's Multiple Comparison Test was used to determine 
differences between the infected and the control group. A P-value ≤ 0,05 was 
considered significant.  
 
3.2.6.  Histology 
 
To determine the presence of trophozoites in the small intestine the tissue samples 
were stained with haematoxylin-eosine (HE).  
 
 
 
3.3. Results 
  
3.3.1. Analysis of the intestinal immune response in infected mice reveals a 
strong IL-17A up-regulation.  
 
In a first trial, we analysed the intestinal immune response in G. muris infected 
BALB/c and C57Bl/6 mice. The daily faecal cyst excretion of the individual animals 
revealed a similar infection pattern as seen earlier in G. muris trials (Belosevic et al., 
1984), with a peak number of cysts around day 5 pi for BALB/c and day 6 pi for 
C57Bl/6 animals (Figure 3.1). Afterwards, cyst shedding rapidly declined. 
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Figure 3.1: cyst excretion in G. muris infected BALB/c mice and C57Bl/6 mice 
Cyst excretion was counted daily using a sucrose density technique. Each point on the 
graph represents the mean cyst output per gram feces of 5 animals ± standard error.  
 
 
Next, we compared the gene transcription of a panel of cytokines in infected animals 
to non-infected controls. This panel consisted of the same cytokines looked at in 
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cattle, i.e. IFN-γ, IL-1β, Il-4, IL-6, IL-10, IL-13, IL-17A, RORγT, TGF-β1 and TNF-
α. A qRT-PCR analysis revealed a striking transcriptional up-regulation of Il17a in 
both infected mice strains (Figure 3.2,). In BALB/c mice, the observed up-regulation 
started from week 1 pi, and further increased on weeks 2 and 3. Except for Il10 at 
weeks 1 and 3 pi, no other cytokine showed a significantly up-regulated gene 
transcription in infected BALB/c mice compared to negative controls. A significant 
down-regulated transcription could be seen for Ifng at week 2 pi as well as a 
transcriptional down-regulation of Tnfa. In C57Bl/6 mice, the up-regulated expression 
of Il17a started at week 1 pi but only showed significance and a much higher fold 
change at week 3 pi. Except for Il6 at week 1 pi, no other cytokine showed a 
significantly up-regulated gene expression in infected C57Bl/6 animals compared to 
negative controls (Figure 3.2, B). A significant down-regulated transcription could be 
seen for Ifng at week 3 pi in infected animals compared to controls. In addition, a 
down-regulation could be seen for Tnfa mRNA at week 1 pi. 
 
  
76	   Chapter 3 	  
	  
 
Figure 3.2. Cytokine transcription profile in the small intestine of G. muris infected 
BALB/c and C57Bl/6 mice.  
Transcription levels of the main cytokines were analyzed using quantitative PCR. Mean fold 
changes (n = 5) in infected mice compared to uninfected controls are presented with SEM as 
error bars. (**P<0.01,  *P<0.05) 
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3.3.2.  Il-17 is required for clearance of G. muris.  
 
Production of IL-17A in the intestine has been described before as critical in the host 
defence against a number of infections such as extra-cellular bacteria (reviewed in 
Korn et al., 2009). To demonstrate whether the transcriptional up-regulation of IL-
17A is important in the immunity against G. muris, a new infection experiment was 
set up in mice deficient for IL-17 receptor A (IL-17RA) on a C57Bl/6J background 
(Ye et al., 2001). After infection of the IL-17R KO animals and C57Bl/6 wild-type 
controls, cumulative cyst counts were significantly higher in KO animals compared to 
controls (Figure 3.3, A). This effect persisted throughout the whole three-week 
duration of the study, after which WT animals were able to largely clear their 
infections while in KO animals high numbers of cysts persisted. In addition, to 
determine the presence of G. muris trophozoites in the gut lumen, samples were taken 
from the small intestine of all animals at day 21 pi for further histological 
examination. A haematoxylin-eosine staining (Figure 3.3, B&C) revealed that only a 
few trophozoites could be found after thorough microscopic examination of the whole 
slide in all WT animals, while a thick layer of trophozoites was still visible in the 
lumen of all the IL-17RA KO mice, indicating that the observed cyst counts are a 
result of the high number of trophozoites remaining in the gut lumen under 
circumstances where IL-17A is unable to execute its function. 
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Figure 3.3. Cyst secretion and presence of trophozoites in G. muris infected IL17RA KO 
animals and wild-type controls. To analyze the effect of the observed il17a up-regulation, 
an infection trial was set up comparing IL-17RA KO animals to infected wild-type controls. 
Panel A shows the mean cummulative cyst output per gram feces of 5 animals ± standard 
error. ** = P<0,01.  Panel B & C show a HE staining to illustrate the lack of trophozoites in 
the intestinal lumen of wild-type controls at week 3 pi (B), whith high numbers of 
trophozoites (arrows) still visible in the intestinal lumen of the KO animals (C).  
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It is noted in literature that the production of IL-17 in mice usually occurs in the 
presence of IL-6 and TGFβ.  However, these cytokines were not found to be 
significantly up-regulated at week 1, 2 or 3 pi in both mouse strains, with the 
exception of Il-6 at week 1 in C57Bl/6 animals. We hypothesized that the cytokines 
upstream of IL-17 may appear earlier on in the infection. We decided to investigate 
this more closely and to set up a new infection trial in which the intestinal response 
was analysed daily starting day 1 pi in C57Bl/6 animals. Both Il-6 and Tgfb1 were 
found to be significantly up-regulated preceding or coinciding the Il-17a up-
regulation that started at day 6 pi (Figure 3.4). In line with its regulatory role, the 
transcription factor Rorc showed a higher transcription in the infected animals 
compared to the controls at the earlier time points.  
 
 
 
 
Figure 3.4. Transcription profile of cytokines in the small intestine of G. muris infected 
C57Bl/6 mice during the first days post infection. The transcription profile of cytokines 
was analyzed starting day 1 pi up to day 7. Mean fold changes (n = 5) in infected mice 
compared to uninfected controls are presented with SEM as error bars. (**P<0.01, *P<0.05) 
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As a first step towards unravelling the effector mechanisms downstream of IL-17A, 
qRT-PCRs were performed to examine the transcription of 6 antimicrobial peptides 
and proteins: the β-defensins (DEFB) 2 and 3, Reg3γ, calprotectin S100A8 and 
S100A9 and cathelicidin. An up-regulated transcription, although not significant, 
could be seen for both calprotectin s100a8 and s100a9 at week 1 pi (Figure 3.5). 
From the remaining genes analysed, cathelicidin was not differently expressed 
compared to control animals and no transcripts of the β-defensins and Reg3γ could be 
amplified or detected in any of the samples. This was however a small preliminary 
study and more thorough investigation of the intestinal transcriptome of both infected 
and non-infected IL-17RA KO and WT mice could provide more detailed information 
on the intestinal effector mechanisms induced by IL-17A production.  
   
 
Figure 3.5. Transcription profile of antimicrobial proteins in small intestine of G. muris 
infected C57Bl/6 mice. Transcription levels of antimicrobial proteins were analyzed using 
quantitative PCR. Mean fold changes (n = 5) in infected mice compared to uninfected 
controls are presented with SEM as error bars. (**P<0.01,  *P<0.05) 
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3.4. Discussion 
 
In this study the general intestinal immune response in mice following a G. 
muris infection was investigated. The most prominent finding was the induction of 
IL-17A following infection, as measured on transcript level by qRT-PCR. The highest 
transcriptional up-regulation was repeatedly observed at week 3 post infection. 
Although some variation was apparent between the different experiments, the data 
indicated that IL-17A induction occurred from approximately 1 week p.i. onwards. In 
addition, when the functioning of this cytokine was impaired by deletion of IL-17RA 
in C57Bl/6 mice, infected animals could no longer dispose of the parasite. In the 
absence of littermate IL-17RA +/+ control mice, infection levels in the IL-17RA KO 
mice were compared to C57Bl/6 wild-type mice. Although mice from different litters 
potentially have a different gut microbiome, it is unlikely that this is causing the lack 
of immune development in the IL-17RA KO mice. Analysis of cyst secretions in 
C57BL/6 WT mice from different origins and in the BALBc mice all showed a 
similar pattern, with the infection almost disappearing at 3 weeks p.i., which is 
completely different from the pattern observed in the IL-17RA KO mice.     
To our knowledge, this is the first time that IL-17A production itself is seen in 
the intestine of G. muris infected mice. Earlier work using the G. muris model did 
identify CD4+ T cells as important elements in the clearance of the parasite, shown by 
the development of prolonged infections in nude mice (Stevens et al., 1978) and mice 
depleted of T helper cells (Heyworth et al., 1987). Since these cells were not further 
characterised, the possibility remains that these were CD4+ Th17 cells. Interestingly, 
when looking at G. duodenalis, an earlier study described an elevated production of 
IL-17 in murine spleen and mesenteric lymph node cells in response to G. duodenalis 
extract (Solaymani-Mohammadi and Singer, 2011), suggesting that an IL-17 response 
could be a typical anti-Giardia response in mice. In addition, cattle infected with G. 
duodenalis showed a systemic IL-17 production after approximately 7 to 9 weeks of 
infection (Grit et al., 2014), at a time that protective immunity develops. Importantly, 
it should be noted that the Il-17RA not only functions as a receptor for IL-17A, but is 
also important for IL-17E and IL-17F signalling. The latter two cytokines however 
never showed an up-regulated transcription in infected mice compared to the controls. 
Interleukin 17 is a cytokine that can be produced by cells that are both part of 
the innate as well as the adaptive immune system. In the intestine of mice, the lamina 
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propria already contains high numbers of CD4+ Th17 cells that are present at steady 
state. Other possible less conventional IL-17 cellular sources include gut RORγT+ γδ 
T cells, CD8+ αβ T cells, invariant natural killer cells, lymphoid tissue inducer (LTi), 
LTi- like cells and paneth cells (reviewed in Morrison et al., 2011).  
The role of IL-17 in the intestine has been described as dual as it can work in 
both a protective and pathological manner. The way it serves as an effector cytokine 
during the clearance of a G. muris infection still needs to be further examined. A 
possible explanation is the stimulation of mucin and defensin production by IL-17 
(Chen et al., 2003; Ishigame et al., 2009), both of which were earlier described as 
candidate defence mechanisms during G. duodenalis infection (reviewed in (Muller 
and von Allmen, 2005)). In our study in C57Bl/6 mice however, no significant 
changes could be observed in the expression levels of 6 antimicrobial peptides and 
proteins that are under the control of IL-17A (i.e. β defensins, Reg3γ, cathelicidin and 
calprotectin), suggesting that other factors are likely in play.  
 In summary, this chapter revealed that a Th17 like response with IL-17A 
production can be observed during a G. muris infection in both BALB/c and C57Bl/6 
mice. The production of IL-17A appeared to be an important factor in the protective 
immune response as was demonstrated in the infection trial using IL-17 receptor A 
KO mice. Whereas in wild type mice cyst secretion dropped significantly after 3 
weeks of infection, the IL-17RA-KO mice were unable to clear the infection. 
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4.1. Introduction 
 
In chapter 2 we described the transcriptional up-regulation of the nuclear 
peroxisome proliferator-activated receptors (PPAR) alpha and gamma in the intestine 
of infected calves. Considering the anti-inflammatory potential of these receptors after 
activation (Daynes and Jones, 2002), this could possibly explain the chronicity of a 
Giardia infection in cattle. In G. muris infected mice (chapter 3), a clear IL-17 
response was observed, in contrast to the downregulated IL-17A transcription in the 
calves. In addition, mice could easily clear the parasite after about 3 weeks of 
infection. 
Following the hypothesis originating from the cattle work that the PPARs 
have a role in the chronicity of the infection and with the clear protective response in 
mice in mind, we would not expect an up-regulated expression of the PPARs in G. 
muris infected mice. In this chapter, the potential induction and activation of PPARs 
in the intestine of infected BALB/c and C57Bl/6 mice were investigated in order to 
further compare these responses in the different mice strains and to the cattle work.  
 
4.2. Material and methods 
 
4.2.1.  Ethical statement.  
 
All animal experiments were conducted in accordance with the E.U. Animal 
Welfare Directives and VICH Guidelines for Good Clinical Practice, and ethical 
approval to conduct the studies were obtained from the Ethical Committee of the 
Faculty of Veterinary Medicine, Ghent University, who have also approved the 
document. 
 
4.2.2.  Mouse studies.  
 
All in vivo experiments performed are summarized in table 4.1. The BALB/c 
and C57Bl/6 animals described in chapter 3, experiment 1 and 2 were used again in 
this chapter. In addition, the samples obtained from the animals used in the early 
immune response work in chapter 3, experiment 4, were used again in this chapter.  
An additional infection experiment (experiment 5) compared Ppara and Pparg 
expression during 7 days of infection in infected BALB/c mice to non-infected 
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BALB/c controls. 
Again in BALB/c animals, experiment 6 used a total of 5 BALB/c mice 
(Harlan laboratories) that received the PPARα agonist fenofibrate (Sigma Aldrich). 
This was given to them by daily oral gavage suspended in olive oil (200mg/ml), at a 
dose of 800mg/kg body weight.  An additional 5 animals were infected with G. muris 
in combination with the daily agonist administration. A third group was infected 
without additional agonist intake and a final group received no agonist or parasite. 
The latter two groups both received the olive oil vehicle only. Cyst excretion was 
counted daily and intestinal samples were taken after 3 weeks of infection.   
In a final experiment (number 7) the course of a G. muris infection in female 
PPARα KO animals (Lee et al., 1995) (of a 10 generations backcrossed C57BL/6N 
genetic background) and in C57Bl/6 WT controls was compared during 3 weeks of 
infection. To achieve this, 5 KO animals and 5 WT mice were infected with G. muris 
cysts after which cyst counts were performed daily for each animal.  
 
4.2.3.  Cyst counts and tissue sample collection. 
 
To monitor the course of a G. muris infection in all trials, cyst excretion in faeces was 
measured as described previously by Roberts-Thomson et al. (1978) (Roberts-
Thomson and Mitchell, 1978) and in chapter 3. Cyst excretion was then expressed as 
number of cysts per gram faeces. In the PPARA KO and agonist trials, statistical 
analysis was done using GraphPad Prism software. All cyst counts from one animal 
were considered as repeated measures and a two way repeated measures ANOVA 
with Bonferroni posttest was used to calculate differences at every time point between 
the groups. 
At necropsy, 1 cm long fragments of the small intestine were taken from each 
animal starting 4 cm from the gastro-duodenal junction. To allow RNA extraction, the 
intestinal tissue was snap frozen in liquid nitrogen and stored at -80°C.  
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Table 4.1. summary of mice experiments  described in chapter 4 
Expt 
nb 
Objective Strain 
 
Age 
(w) 
Sex Trial 
duration 
Number of 
animals 
Time 
point of 
sampling 
pi1 
Analyzed 
data2 
1 Intestinal 
immune 
response 
BALB/c 6  F 3 weeks 15 infected  
5 negative 
controls 
Week 1 
Week 2 
Week 3 
Cyst 
excretion 
Intestinal 
PPAR 
levels 
2 Intestinal 
immune 
response 
C57Bl/6 6  F 3 weeks 15 infected  
5 negative 
controls 
Week 1 
Week 2 
Week 3 
Cyst 
excretion 
Intestinal 
PPAR 
levels 
4 Early 
intestinal 
immune 
response 
C57Bl/6 6  F 1 week 35 infected  
14 negative 
controls 
Daily, 
starting 
day 1 pi 
until day 
7 
Intestinal  
PPAR 
levels 
5 Early 
intestinal 
immune 
response 
BALB/c 6  F 1 week 35 infected  
14 negative 
controls 
Daily, 
starting 
day 1 pi 
until day 
7 
Intestinal 
PPAR 
levels 
6 Effect of 
PPARα 
agonist on 
intestinal 
immune 
response 
BALB/c 6 F 3 weeks Infected: 5 
plus 
agonist, 5 
without 
Negative 
controls: 5 
plus 
agonist, 5 
without 
Week 3 Cyst 
excretion 
Intestinal 
cytokine 
levels 
7 Effect of 
PPARα 
deletion 
on the 
intestinal 
immune 
response 
C57Bl/6 
PPARα 
KO 
6 F 3 weeks 5 infected 
PPARα KO 
mice 
5 infected 
controls 
NA Cyst 
excretion 
 
1 samples were taken from the small intestine for subsequent qRT-PCR analysis of the main 
cytokines. 2 cyst counts in faeces were performed daily for each animal  
 
 
 
90	   Chapter 4 	  
	  
4.2.5. RNA isolation and quantitative real time PCR.  
 
Total RNA was isolated by adding TRIzol (Invitrogen) to the snap-frozen tissue 
followed by an RNA purification with the RNeasy mini kit (Qiagen). Any 
contaminating genomic DNA was removed with the help of the RNase-free DNase set 
(Qiagen) for on-column DNase digestion. An ExperionTM Automated Electrophoresis 
System (Bio-Rad) was used to verify the quality of the isolated RNA, while total 
RNA concentrations were determined using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies). To obtain the cDNA samples needed for quantitative Real-
time PCR (qRT-PCR) the iScript cDNA synthesis kit was used following the 
manufacturer’s instructions.  
All qRT-PCR analyses were carried out as described in chapter 3. Statistical 
analysis was carried out using GraphPad Prism software. A one way ANOVA 
followed by a Dunn's Multiple Comparison Test was used to determine differences 
between the infected and the control group. A P-value ≤ 0.05 was considered 
significant.  
 
4.3. Results 
 
4.3.1.  Peroxisome proliferator-activated receptor (PPAR) α gene 
transcription is up-regulated early on in infection in C57Bl/6 mice 
 
A qRT-PCR analysis was used to check the transcription profile of both Pparg  
and Ppara (Figure 4.1.) in BALB/c and C57Bl/6 mice. In BALB/c animals, no up-
regulation of Pparg could be seen, and transcription was even significantly down-
regulated at week 2 pi. Concerning Ppara and its downstream genes, no significantly 
increased transcription was observed in infected animals. In C57Bl/6 mice, like in 
BALBc’s, no up-regulation could be seen whatsoever for pparg transcription. 
Concerning Ppara, C57Bl/6 mice showed up-regulations bordering the 2-fold 
threshold at week 1 pi and over 2-fold at week 2 and 3, although not statistically 
significant.  
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Figure 4.1.: PPAR transcription profile in small intestine of G. muris infected 
BALB/c and C57Bl/6 mice. 
Transcription levels of the PPARs were analyzed using quantitative PCR. Mean fold 
changes (n = 5) in infected mice compared to uninfected controls are presented with 
SEM as error bars.  
 
 
Additional qRT-PCR analyses of Ppara were done on the intestinal samples 
collected daily from C57bl/6 animals starting day 1 pi up until day 7 pi (mentioned in 
chapter 3). This indicated a transcriptional up-regulation of Ppara from day 1 pi 
onwards in the infected animals compared to the negative controls (Figure 4.2). To 
investigate whether a possible up-regulation of Ppara expression also results in a 
functional PPARα activation, three genes (pyruvate dehydrogenase kinase, isozyme 4 
(Pdk4), carnitine palmitoyltransferase 1a (Cpt1) and phospholipid transfer protein 
(Pltp)) that are known downstream targets of PPARα (Lefebvre et al., 2006) (typically 
measured in liver samples) were included in the qRT-PCR analysis. An up-regulation 
was observed for 2 of the downstream target genes, with a significant up-regulation of 
Pdk4 and Pltp mRNA levels starting day 1 pi, suggesting that the observed Ppara up-
regulation could indeed be linked to a functional PPARα activation. No up-regulation 
of Pparg expression could be observed. Repeating the same experiment in BALB/c 
animals revealed no significant up-regulation of Ppara, Pparg or the downstream 
target genes at any timepoint (Figure 4.3.) 
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Figure 4.2. Transcription profile of PPARα and the main downstream target genes in 
the small intestine of G. muris infected C57Bl/6 during the first days post infection. The 
transcription profile of of Pparγ, Pparα and the selected downstream target genes was 
analyzed starting day 1 pi up to day 7. Mean fold changes (n = 5) in infected mice compared 
to uninfected controls are presented with SEM as error bars. (**P<0.01, *P<0.05) 
 
Figure 4.3. Transcription profile of PPARα and the main downstream target genes in 
the small intestine of G. muris infected BALB/c during the first days post infection. The 
transcription profile of Pparγ, Pparα and the selected downstream target genes was analyzed 
starting day 1 pi up to day 7. Mean fold changes (n = 5) in infected mice compared to 
uninfected controls are presented with SEM as error bars.  
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4.3.2. PPARα might influence cyst excretion numbers, but has no influence 
on infection duration or immune development.  
 
To unravel any potential influence of PPARα on a Giardia muris infection,  
two approaches were used. Since no PPARα activation was observed in BALB/c 
mice, a PPARα agonist was used to induce activation of the receptor. Since C57Bl/6 
animals did show an upregulated transcription of PPARα, an infection experiment 
was set up where C57Bl/6 animals with a deletion of PPARα were infected.  
The BALB/c mice were given a PPARα specific agonist (fenofibrate) in 
combination with G. muris. Infected mice were given their daily dose of fenofibrate, 
whilst another group received the parasite but not the agonist. In addition, one group 
of animals received neither the agonist nor the parasite and served as a negative 
control group. To check if the agonist indeed resulted in an upregulated transcription 
of Ppara in the intestine, an agonist control group consisting of non-infected animals 
receiving only the agonist was introduced. As shown in figure 4.4, administration of 
the agonist led to noticeable lower cyst counts than those observed in the infected 
control animals. Both groups were nonetheless able to clear the infection by day 21, 
indicating that PPARα had no influence on the final outcome of a protective immune 
response and thus the (timing of the) eventual elimination of G. muris.  
Comparison of the qRT-PCR data (Figure 4.5, panel A) obtained from the 
fenofibrate treated infected group with the negative control showed a significant up-
regulation of Ppara transcription after 3 weeks of infection. In contrast to the first 
infection trial, the elevated Ppara transcription could also be seen in the infected 
BALB/c animals that did not receive any agonist. Looking at the downstream genes 
Pdk4, Pltp and Cpt1, all showed a higher transcription, with a significant result for 
Cpt1 in the infected agonist group.  
The calculated fold changes for cytokine transcription in the different groups 
suggest that PPARα agonist administration might have no or little effect on cytokine 
production as Il17a transcription was still up-regulated in the infected groups 
compared to the controls, although with markedly lower fold changes than those seen 
in earlier trials.  
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Figure 4.4. Cyst excretion in fenofibrate treated BALB/c animals. 
Cyst counts were performed daily starting day 5 pi until 3 weeks pi. Each point on the 
graph represents the mean cyst output per gram feces of 5 animals ± standard error.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Intestinal transcription profile in fenofibrate treated BALB/c animals. 
Quantitative RT-PCR was used to analyze the transcription profile in the intestine of 
G. muris infected animals administered with the PPARα agonist fenofibrate (agonist + 
Giardia), infected mice without agonist administration (only Giardia) and uninfected 
mice treated with the agonist (agonist control).  Mean fold changes (n = 5) at week 3 
pi when comparing previous groups to uninfected untreated controls are presented 
with SEM as error bars (*P<0.05) 
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In a second experiment we compared the time course of infection between 
C57BL/6 WT and C57Bl/6 PPARα KO mice by counting the cyst excretion in both 
groups. To achieve this, cysts were counted daily starting day 5 pi up to week 3. 
Overall, no clear difference could be seen in the amount and duration of cyst 
excretion apart from day 5 pi, when cyst excretion in the KO animals was higher than 
what was seen in the control mice (Figure 4.6A) and the opposite effect on day 7 and 
8 pi, although only statistically significant at day 8. To investigate whether cyst 
excretion already occurred earlier than day 5 pi in the PPARα KO mice, a second 
experiment was performed in which cyst excretion was measured daily starting from 
day 1 pi till day 7 pi. The results of this experiment are shown in figure 4.6B. Similar 
as in the first experiment, cyst excretion was detectable from day 5 pi onwards in the 
PPARα KO mice, whereas cyst excretion in the WT animals only started from day 6 
pi onwards. On day 7 however, no more difference could be seen between the groups.  
Quantitative RT-PCR analyses in both the WT and KO mice revealed that 
after deletion of PPARα, Il17a transcription was still significantly upregulated at 
week 1 and 3 pi in KO mice compared to uninfected negative controls. The WT 
animals that were included in this study again showed the up-regulated expression of 
Il-17A that was observed in the earlier trials at both week 1 and statistically 
significant at week 3 pi with a fold change of respectively 7 and 11 compared to 
negative WT controls (Figure 4.7). 
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Figure 4.6. Comparison of infected PPARα KO mice and WT controls. Panel A 
shows the cyst counts of the first trial where counting started at day 5 pi, panel B 
shows the results of a second trial where counting was done daily starting day 1 pi 
untill day 7. Each point on the graph represents the mean cyst output per gram feces 
of 5 animals ± standard error.  
 
 
 
*	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Figure 4.7. Transcription levels of il17a in PPARα KO and WT C57Bl/6 mice. 
Quantitative RT-PCR was used to analyze the transcription profile in the intestine of 
G. muris infected C57Bl/6 PPARα KO and WT mice.  Mean fold changes (n = 5) at 
week 1 and 3 pi calculated by comparing previous groups to uninfected untreated 
controls are presented with SEM as error bars (*P<0.05).	  
 
 
4.4. Discussion 
 
In this chapter, the possible activation and role of PPARα and γ in G. muris 
infected mice was investigated. The qRT-PCR analysis on intestinal samples showed 
that both ppara and pparg transcription was not up-regulated in infected BALB/c 
mice. However, an up-regulated Ppara transcription could be seen after 3 weeks of 
infection in a different experiment. The qRT-PCR analysis in C57Bl/6 mice indicated 
that PPARα mRNA, but not PPARγ, was up-regulated in infected mice as soon as day 
1 pi. The exact mechanism by which PPARα is induced and activated during an 
infection is still unclear since a variety of ligands produced by the host or the parasite 
could be responsible (discussed in chapter 2). 
It appears that PPARα activation in BALB/c mice might have an influence on 
the number of cysts that are excreted by infected mice. This was shown by the lower 
cyst counts in animals receiving an agonist compared to non-agonist controls. In 
C57Bl/6 animals, a clear effect on cyst counts was not as apparent. However, in these 
animals, higher transcription levels of PPARα were observed than in BALBc’s, while 
the established peak of cyst excretion remained lower and appeared one day later. In 
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addition, cyst secretion during the 3 weeks period of the study in the PPARα KO 
animals was not majorly affected by the absence of PPARα, although a higher cyst 
excretion was repeatedly observed on day 5 pi in the KO animals compared to WT 
mice. How PPARα could influence cyst production is still unclear but it is possible 
that the levels of cholesterol, bile acids and bile salts in the intestinal lumen have a 
role in this. All these factors have been shown to influence Giardia encystation 
(Adam, 2001) and are also a target or a part of the various metabolisms that are 
influenced by PPARα (Valasek et al., 2007).  
As stated before, the PPARs can exert a suppressive effect on the immune 
response. We previously hypothesised that this effect might cause the chronic 
infection witnessed in calves infected with G. duodenalis, since in these animals a 
lack of immune respons was seen together with an up regulated transcription of 
PPARα and PPARγ. However, administration of the PPARα agonist to BALB/c 
animals did not exert any effect on the duration of an infection, since both the agonist-
treated and the control animals were able to clear the infection after approximately 3 
weeks. This was further confirmed in the PPARα KO experiment, since the KO 
animals were able to clear the infection similar as the WT mice. 
Whether the PPARα activation has any influence on the kinetics of the IL-17A 
response early in the infection is still unclear, but it is interesting to note that the IL-
17A production in C57Bl/6 animals only starts when the PPARα activation is largely 
gone. However, the deletion of PPARα does not seem to have a great effect on IL-
17A expression considering that il17a still showed an up-regulated expression in 
PPARα KO animals, and agonist administration to BALB/c animals did not lower 
Il17a transcription. Further research is needed to unravel this potential regulatory role 
of PPARα in the IL-17 response.  
It should be noted that the role of PPARγ likewise warrants further research. 
Several studies have previously shown the association between PPARγ and Th17 
response suppression (Klotz et al., 2009; Park et al., 2009; Viladomiu et al., 2012) and 
earlier work in G. duodenalis infected cattle revealed an up-regulation of PPARG 
together with a significant down-regulation of IL-17A (chapter 2). Since no PPARγ
activation was observed in G. muris infected mice, it would be interesting to in future 
adopt a reverse strategy by activating PPARγ in mice and subsequently monitor 
possible effects on G. muris and immune development. Unfortunately, initial 
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experiments with agonists failed to activate PPARγ in the intestine of mice (results 
not shown).   
 In summary, this study revealed an early induction of PPARα in the intestines 
of G. muris infected C57Bl/6 mice. This upregulated expression was not seen at later 
time points in BALB/c mice, but needs to be examined at the earlier stages of 
infection. The upregulated transcription of Ppara could possibly influence the number 
of cysts that are excreted in the faeces of the host. It does not however seem to 
influence the duration of an infection or the intestinal host response. Further research 
is now needed to elucidate the cells and mechanisms involved in the induction and 
regulatory functions of PPARα. 
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The objective of this thesis was to understand the origin of the chronicity 
observed in cattle infected with Giardia duodenalis by performing a detailed analysis 
of the intestinal response. In addition, the immune response in G. muris infected mice 
was looked at and compared with the findings in G. duodenalis infected cattle. In this 
final chapter, the results of these studies will be discussed as well as the future 
prospects of this research.  In addition, an idea will be given of the possible 
applications of this thesis.  
 
5.1. Giardia spp. and interleukin 17.  
 
Infection with G. muris induced a strong up-regulation of IL-17A in the 
intestine of both BALB/c and C57Bl/6 mice. The importance of IL-17A in 
orchestrating the protective immune response was later demonstrated in an infection 
trial using IL-17 receptor A KO mice: whereas in wild type mice cyst secretion 
dropped significantly after 3 weeks of infection, the IL-17RA-KO mice were unable 
to clear the infection. In cattle infected with G. duodenalis, we observed a suppression 
of IL-17A during acute infection (chapter 2). However, additional work done in our 
lab by Grit et al. (2014) investigated the kinetics of the immune response in infected 
animals until they showed immune protection against a re-infection, which occurred 
after approximately 3 months of infection. The first signs of an adaptive immune 
response only became visible after approximately 9 weeks of infection, as 
characterized by a significant proliferation of IL-17A producing CD4+ αβ T cells 
following in vitro re-stimulation of peripheral blood mononuclear cells (PBMC) with 
G. duodenalis antigens.  
IL-17A is a rather unique cytokine that bridges innate and adaptive immunity. 
Its role in the intestine has been described as dual with both protective and 
pathological effects. The cytokine can be produced by the more conventional CD4+ 
αβ T cells or by a range of innate immune cells (such as amongst others LTi cells, γδ 
T cells and paneth cells) that can act as sentinels of the immune system and reside in 
the intestinal lamina propria and intraepithelial compartment close to the host-
environment interface (Cua and Tato, 2010). Another possible IL-17 producing cell 
population in the gut are the paneth cells (Takahashi et al., 2008). In mice specifically, 
intestinal production of IL-17A could be attributed to γδ T cells, which can provide an 
early innate IL-17 response  since toll like receptors can directly activate mouse γδ T 
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cells to induce IL-17 (Gibbons and Spencer, 2011). Similar to Th1 or Th2 cells, 
differentiation of CD4+ αβ T cells into IL-17A producing cells requires T cell receptor 
recognition of its cognate antigen presented on major histocompatibility complex 
class II by professional antigen-presenting cells such as dendritic cells (DCs) 
combined with the production of IL-6 and TGF-β (Korn et al., 2009). Unlike Th17 
cells, antigenic priming is not required for activation of the innate immune cells, for 
which IL-23 stimulation, produced by antigen presenting cells, is sufficient to switch 
on IL-17A secretion (Cua and Tato, 2010). The data obtained so far suggests that the 
observed IL-17A production following infection is a result of a Th17 response. In 
immune cattle, in vitro exposure of PBMCs to Giardia trophozoites resulted in the 
proliferation of IL-17A producing CD4+ αβ T-cells (Grit et al., 2014). In mice, the 
intestinal up-regulation of IL-17A was preceded by increased expression of IL-6, 
TGF- β and ROR-γt, which are required to induce IL-17A expression in T-cells 
(Gibbons and Spencer, 2011). In addition, CD4+ T cell deficient mice are unable to 
clear a Giardia infection (Singer and Nash, 2000). However, additional experimental 
evidence is needed to fully confirm this hypothesis.  
Since our attempted immunohistological stainings for IL-17A on intestinal 
tissue of infected mice were not successful, further research is needed to identify the 
real cellular source. A possible approach is the use of RORγt GFP transgenic mice in 
a new infection trial. After infection, the number of GFP-positive cells can be 
quantified and phenotyped using flow cytometry. In addition, the IL-17A response 
following Giardia infection in cattle was only investigated and observed in acutely 
infected calves (chapter 2) and systematically in long term infected animals (Grit et 
al., 2014). Future work on these animals regarding IL-17A could therefore first focus 
on analysing the intestinal expression in chronically infected cattle. Afterwards, the 
cellular source of IL-17 production in the intestine can be identified using flow 
cytometry.  
In general, IL-17A is critical for mucosal and epithelial host defense against 
extracellular pathogens by enhancing the production of tight junction proteins, 
mucins, antimicrobial proteins and chemokines (Cua and Tato, 2010). Previous 
studies have alluded to the importance of all these factors in the defence against 
Giardia, but in vivo evidence is still missing (Muller and von Allmen, 2005). On the 
other hand, it has also been reported that IL-17A can contribute to chronic 
inflammation associated with a parasitic infection. In the C57Bl/6 mice study, no 
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significant changes could be observed in the expression levels of a panel of 
antimicrobial peptides and proteins that are under the control of IL-17A (i.e. β 
defensins, Reg3γ, cathelicidin and calprotectin), suggesting that other factors are 
likely in play. This was however a small preliminary study and more thorough 
investigation of the intestinal transcriptome (using an RNA-seq approach) of both 
infected and non-infected IL-17RA KO and WT mice could provide more detailed 
information on the intestinal effector mechanisms induced by IL-17A production. The 
functional role of possible effector molecules brought forward by the RNA-seq 
analysis can then be further investigated by performing infection experiments in KO 
mice, pending availability. When the results still point to antimicrobial peptides, their 
effect on the viability of life trophozoites could be analysed in culture. The 
differential expression of the genes and transcripts that are thus identified in mice 
could also be analysed in the mucosal samples collected from the immune calves 
using qRT-PCR.  
 
5.2. Giardia spp. and the peroxisome proliferator –activated receptor alpha 
 
In the second chapter of this thesis, it became clear that an infection with G. 
duodenalis in cattle coincided with a concomitant intestinal PPARα and PPARγ up-
regulation. These nuclear receptors are ligand activated transcription factors that 
comprise three isotypes (α, β/δ and γ) differing in tissue distribution and cellular 
functions (Michalik et al., 2006). All of these receptors combine an ability to 
modulate lipid and glucose homeostasis with the regulation of innate and adaptive 
immune responses (Wahli and Michalik, 2012). When the infection trials were 
repeated using G. muris in mice, an early up-regulation of PPARα could be seen in 
C57Bl/6 mice. In mice infected with G. muris, no up-regulated expression of pparg 
occurred. In addition, the ppara expression disappeared within one week of infection, 
followed by a Th17 response. In BALB/c mice, PPARα did not show an up-regulated 
expression at any timepoint during the initial infection experiment. It should however 
be noted that in the agonist trial, G. muris infected animals that were not administered 
with fenofibrate did show an up-regulated expression of PPARα at week 3 pi.  
 A number of endogenously present metabolites can induce and activate 
PPARα, such as the fatty acids and their derivatives (Daynes and Jones, 2002). It is 
unclear which are the ligands responsible for the observed PPARα activation during a 
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Giardia infection.  The question remains if the PPARα activation observed in cattle 
and mice is secondary to the infection and triggered by host fatty acid metabolites or 
instead by lipids of the parasite.  A possible approach to identify if lipids extracted 
from Giardia are acting as ligands for PPARα would be to combine an in vitro 
enterocyte culture system and a PPARα-dependent transcriptional system (Raspe et 
al., 1999).  
One of the many biological effects that are attributed to the PPARs is their 
influence on inflammation and immunity. In both in vitro and in vivo models, the 
PPARs have shown a potent anti-inflammatory effect, shown for example in PPAR 
KO mice. The PPARs can influence the immune response through transrepression 
mechanisms that can suppress the activity of many transcription factors such as NF-
κB, STATs and AP1 (Straus and Glass, 2007). There are different modes of action 
available to the PPARs to execute this transrepression, which depend more on 
protein-protein interaction than the more classical protein-DNA interactions that are 
attributed to transcription factors. First, the use and sequestration of certain co-
activators by the PPARs makes them unavailable for other transcription factors and 
secondly PPAR-RXR heterodimers have the ability to bind to other transcription 
factors, resulting in cross-inhibition. Thirdly, PPARs can interfere with mitogen-
activated protein kinase (MAPK) and prevent it from activating any downstream 
transcription factors (Daynes and Jones, 2002). The PPARs have been shown to have 
mechanistic roles in both innate and adaptive immunity, leading to immune 
suppression. This is no surprise considering their expression in immune cells such as 
dendritic cells, T cells, B cells and macrophages as well as in epithelial cells (Straus 
and Glass, 2007). The in vivo role of PPARα activation in relation to infection is still 
unsure. Taken into account the described anti-inflammatory and immune repressing 
abilities, we first hypothesized that their up-regulated transcription was the main 
reason of the long-lived Giardia infections in cattle. This was further supported by the 
lack of immune response, inflammation or immune cell recruitment in the intestine of 
these animals. However, further work in mice infected with G.  muris revealed that 
PPARα had no influence on infection duration since the administration of a PPARα 
agonist or the deletion of PPARα did not alter the speed at which the infection was 
cleared nor the ability of the animals to raise an IL-17A response. It does however 
appear that BALB/c animals show a stronger up-regulated transcription of il17a than 
seen in C57Bl/6 animals in combination with an absence of ppara up-regulation.  
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Intriguingly, recent studies have also shown a potential pro-inflammatory 
effect of PPARα ligands. This has been shown by the teams of Prof. K. De Bosscher 
and Prof. B. Staels (unpublished results) in a systemic TNF treatment-model where an 
unexpected pro-inflammatory effect of PPARα on liver cytokines was seen. Such pro-
inflammatory role for PPARα has additionally been observed in a mouse model of 
endotoxemia in which dietary PPARα agonist treatment resulted in higher LPS-
induced TNF plasma levels than in LPS-treated control-fed animals (Hill et al., 1999). 
A worsening of inflammation was also observed in a rat model of glomerulonephritis 
after treatment with a PPARγ agonist (Panzer et al., 2002). However, up until now, 
the effects of PPARs in relation to parasites have always appeared to be anti-
inflammatory and immune suppressing (Chan et al., 2010). This is most likely so in 
the Giardia infected cattle, and considering the delay of IL-17A up-regulated 
expression until after the up-regulated expression of PPARα has disappeared, this also 
seems to be the case in mice.  
 The effect PPARα induction and activation might have on the host-parasite 
interaction stretches far beyond immune-modulation. The receptor plays an important 
role in the metabolic response to nutritional and environmental factors as is shown by 
its influence on the lipid metabolism (Varga et al., 2011). As a resident of the 
intestinal lumen, Giardia is subject to a variety of both host produced and dietary 
lipids. An important lipid for giardial growth which the parasite cannot produce de 
novo is cholesterol. The depletion of cholesterol, be it by epithelial absorption in the 
intestine or bacterial metabolisation, triggers the encystation of the trophozoites 
(Arguello-Garcia et al., 2009). Activation of PPARα reduces the absorption of 
luminal cholesterol by epithelial cells and induces higher excretion of the lipid via 
bile into the intestine (Valasek et al., 2007). One way PPARα executes its influence 
on cholesterol transport in the epithelium is by activating ATP-binding cassettes 
transporters. In chapter 2, the microarray analysis revealed an up-regulated 
transcription of ABCG8, a transporter that opposes the absorption of dietary sterols 
and promotes the excretion of cholesterol (Back et al., 2013). In addition, PPARα 
activation will decrease the amount of bile acids that are excreted in the intestine (Ito 
et al., 2013). These bile acids are important for the digestion of lipids in the intestinal 
lumen and would make cholesterol less available to the trophozoites (Arguello-Garcia 
et al., 2009). Theoretically, the higher abundance of lipids in the intestinal lumen 
would be beneficial for the parasite and could lower the need for encystation. This 
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could then explain the lower cyst excretion seen in infected C57Bl/6 mice compared 
to BALB/c animals (chapter 3).  It this respect, it would be interesting to investigate 
the lipid content of faecal material of both infected and non-infected mice.  
 In production animals, changes in the metabolism of an animal could result in 
significant economical losses. Previous research on G. duodenalis infections in sheep 
has revealed that animals do suffer weight loss after infection (Olson et al., 1995), 
while experimental infection in goats described a decrease in appetite in infected 
animals (Koudela and Vitovec, 1998). Taking into account the modulatory role of 
PPARα on lipid and glucose metabolism, it is not unlikely that the nuclear receptor is 
related to the metabolic changes observed during Giardia infection. This has been 
shown already in rodents, where PPARα was related to weight loss, appetite 
suppression and satiety (Fu et al., 2003; Gutman et al., 2012; Perreault et al., 2010). In 
addition, diarrhea associated with a Giardia infection is often described as being 
mucoid or even fatty. This could again be explained by the increase of lipid content in 
the faeces after PPARα activation.  
 
5.3. Giardia spp. and the peroxisome proliferator –activated receptor gamma 
 
The question remains why in cattle it takes several months before IL-17A 
production can be seen after G. duodenalis infection, while in mice a protective 
response against G. muris is observed after 3 weeks with IL-17A up-regulation 
starting at 1 week pi. A possible cause of the different host responses to the different 
parasites could be the induction of PPARγ that was seen in cattle and not in mice. 
This subtype of the receptor has been directly linked to a suppression of IL-17 (Klotz 
et al., 2009; Park et al., 2009; Viladomiu et al., 2012). This regulatory function of 
PPARγ has been shown in both humans and mice end leads to a selective suppression 
of Th17 differentiation (but not the differentiation of T cells into Th1, Th2 or 
regulatory T cells) by controlling RORγt (Klotz et al., 2009).   
Why activation of this receptor occurs in cattle and not in mice could be due to 
the difference in parasite species or the difference in host species. Interestingly, after 
being incubated with G. duodenalis for 18 hours, human intestinal Caco-2 cells 
showed an up-regulation of PPARγ, suggesting the same mechanism might also be 
active in humans infected with G. duodenalis (Roxstrom-Lindquist et al., 2005). To 
rule out the host species as a determining factor for the absence or presence of PPARγ 
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induction, it would be interesting to repeat the experiments using G. duodenalis in 
mice and again look at the transcriptional profile of the PPARs.  
It should however be noted that G. duodenalis infections in mice often last 
only a short duration of time, with the elimination phase of an infection starting after 
around a month (Byrd et al., 1994). In this sense, it seems unlikely that PPARγ 
activation will be present in its role as advocator of an anti-inflammatory response 
and that a Th-17 response will be present. In addition, using this model raises the 
question if administration of Giardia in such high quantities and in a trophozoite form 
is a realistic representation of an infection in a natural host to G. duodenalis.  
 
5.4. Conclusions and future prospects 
 
In this thesis it became clear that calves infected with G. duodenalis do not 
mount any immune response to the parasite in the intestine during the first few weeks 
of infection but did show an activation of the PPARs. In G. muris infected C57Bl/6 
mice, we could confirm an early up-regulation of PPARα but not PPARγ. No up-
regulated transcription of any of these PPARs could be seen in BALB/c mice 
(although in the agonist trial, ppara up-regulation could be seen in the infected group 
at week 3 pi). After about one week of infection, a strong IL-17A response followed. 
This cytokine likely is crucial in the protection against the parasite, since IL-17RA 
KO animals were unable to clear infection in contrast to the infected WT mice.  
Although G. duodenalis is not the most devastating pathogen in the intestine 
and often infections go by without overt inflammation of the intestinal tissue, it has 
been linked to production losses in ruminants. Clearing an animal of Giardia is not 
easy: treatment is difficult and does not prevent reinfection. Most animals will 
experience a new uptake of the parasite only shortly after treatment. 
With this knowledge, the idea of a preventive measure such as a vaccine 
becomes more attractive. The purpose of a vaccine is to induce or stimulate a 
protective immunological memory reaction in the host to a foreign agent. The work 
presented in this thesis suggests that in the case of Giardia this is a Th17 like 
response.   
 It has been described before that certain vaccines require the induction of a 
memory Th17 response for the vaccine to be effective. Antigen specific Th17 
inducing vaccination gave protection against Bordetella pertussis (Higgins et al., 
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2006), Mycobacterium tuberculosis (Khader et al., 2007) and rotavirus (Smiley et al., 
2007) in murine models.  Most of their success laid in the use of the appropriate 
adjuvant. For IL-17 induction, adjuvantia such as dimethyl dioctadecylammonium 
bromide + monophosporyl lipid, fungal β-glycan end fungal hyphae have been 
described and tested successfully. Concerning the intestine specifically, systemic 
immunisation using lipopolysaccharide (LPS) as an adjuvant gave a potent intestinal 
Th17 priming, with high numbers of Th17 cells in the lamina propria of the murine 
intestine (McAleer et al., 2010). Although IL-17A production might be beneficial in 
the response to Giardia, it is still necessary to remain careful with the induction of an 
IL-17 response through vaccination. The role of IL-17A has been described as dual, 
on one hand IL-17A can be protective for the intestinal tissue, but on the other, 
uncontrolled production (as seen during autoimmune disease) can lead to tissue injury 
and damage. To fully understand how the production of IL-17A could give a safe 
protection against Giardia, we need more information on the onset and regulation of 
the IL-17A response.  
 Boosting the immune response through vaccination might also raise another 
issue. Consistent with the work presented in chapter 2, a recent development in the 
Giardia field are studies that report on an “immune-modulatory” effect of the parasite 
(Cotton et al., 2014), leading to immune suppression or a reduction/absence of 
inflammation in the intestine. In addition, work done in humans has revealed that the 
severity and incidence of diarrhea in children may be reduced by the presence of 
Giardia alone or as part of a co-infection with a diarrhea causing pathogen (Bilenko et 
al., 2004; Muhsen et al., 2013; Veenemans et al., 2011). However, other studies still 
link Giardia infection to clinical disease or do not see a beneficial effect on diarrhea 
of (co-)infection with Giardia (Bhavnani et al., 2012) . Here it could be questioned 
again if a difference in assemblage leads to a different response.  
 The microarray work done in the calves (chapter 2) revealed the PPARs as 
possible modulators of the absence of an immune response in the infected animals. 
The work done in G. muris mice questioned the role of PPARα in the regulation of the 
immune development. However, PPARγ is still an interesting candidate to solve the 
problem of immune suppression during a Giardia infection. As mentioned before, 
PPARγ has a direct and specific suppressing effect on IL-17A production. In this 
aspect, inhibition of PPARγ through the use of inhibitors or antagonist could enable 
the development of a protective Th17 response during infection. For now, PPARγ 
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antagonist have mostly been used in research concerning diabetes, obesity and cancer. 
The consequence of the use of these molecules on the entire body or in certain organs 
is not known. It should be noted that PPARγ, as is the case with PPARα, can be found 
in numerous types of cells and has a role in many different aspects of the metabolism. 
A specific example of the influence of PPARγ in the intestine is the maintenance of 
gut homeostasis. A study by Kelly et al. (2004) described that commensals used a 
PPARγ-dependent mechanism to dampen intestinal inflammation. With this 
knowledge in mind, additional research is needed on different aspects of PPARγ 
induction, regulation and functioning before it is feasible to temper with this receptor 
in the intestine. 
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The protozoan parasite Giardia duodenalis is a highly present pathogen around the 
globe in a vast array of hosts. Once ingested, Giardia can induce intestinal symptoms 
(such as diarrhea, nausea and abdominal cramps) and could cause significant 
production losses in animals such as cattle. Although infections can regularly pass by 
unnoticed and rapidly, a number of patients experience giardiosis as a persistent and 
chronic disease. When looking at cattle, the chronicity is a given for any infection, 
with cyst excretions lasting well over 100 days. Although we have already some 
knowledge on the immune response in these animals and other natural hosts, the 
reason behind the observed chronicity is still unclear and Giardia induced host-
pathogen interactions remain incompletely defined.  
 
Therefore, the overall aim of this thesis was to unravel the intestinal host response in 
chronically infected cattle and to compare the results to what is happening in G. muris 
infected mice, in which the infections are short-lived. In this way, we attempted to 
identify the origin of the differences in infection duration.  
 
The first step in the research presented in this thesis (chapter 2) was to investigate the 
intestinal response in calves following a G. duodenalis infection using a bovine high-
density oligo microarray to analyze global gene expression in the small intestine. The 
resulting microarray data suggested a decrease in inflammation, immune response, 
and immune cell migration in infected animals. These findings were examined in 
more detail by histological analyses combined with quantitative real-time PCR on a 
panel of cytokines. The transcription levels of IL-6, IL-8, IL-13, IL-17, and IFN-γ 
showed a trend of being downregulated in the jejunum of infected animals compared 
to the negative controls. No immune cell recruitment could be seen after infection, 
and no intestinal pathologies, such as villus shortening or increased levels of 
apoptosis. Possible regulators of this intestinal response were the nuclear peroxisome 
proliferator-activated receptors alpha (PPARα), and gamma (PPARγ), all for which an 
upregulated expression was found in the microarray and qRT-PCR analyses.  
 
In chapter 3, the objective was to gather further insights in the intestinal host response 
by using a murine giardiosis model where BALB/c and C57Bl/6 mice are infected 
with their natural parasite Giardia muris. Again, qRT-PCR was used to analyse 
118	   Summary 	  
	  
cytokine transcription patterns in intestinal tissue at different time-points during 
infection. In all mice, a strong up-regulation of Il17a could be observed starting 
around 1 week post infection. The significance of IL-17A in orchestrating a protective 
immune response was unequivocally demonstrated in an infection trial using IL-17 
receptor A C57Bl/6 KO mice: whereas in wild type C57Bl/6 mice cyst excretion 
dropped significantly after 3 weeks of infection, the IL-17RA-KO mice were unable 
to clear the infection. 
 
In chapter 4, the aim was to investigate the expression of the peroxisome proliferator-
activated receptors in the intestine of G. muris infected mice, based on the work in 
chapter 2 where these receptors showed an up-regulated expression in Giardia 
infected calves. No up-regulation could be seen for PPARγ in both mice strains, and 
in addition, no up-regulated expression was seen for PPARα in BALB/c animals. 
Analysis of the intestinal response in C57Bl/6 mice however revealed a PPARα 
induction soon after the initial contact with the parasite, as characterized by the 
transcriptional up-regulation of Ppara itself and several downstream target genes such 
as Pltp and Cpt1. This induction of PPARα did not seem to have any influence on the 
immune response against G. muris since BALB/c mice administrated with a PPARα 
agonist and PPARα KO C7Bl/6 animals expressed Il17a and could clear the infection 
similar to WT controls.  
 
Overall, we concluded that IL-17A is likely to be a crucial cytokine in the response to 
Giardia infection and the elimination of the parasite. In cattle it seemed that the 
PPARs were responsible for the lack of immune response because of their anti-
inflammatory and immune suppressing characteristics, but this could not be clarified 
in G. muris infected mice when looking at PPARα. This nuclear receptor showed an 
up-regulation early on in infection but did not seem to influence infection duration. In 
future it will be interesting to look at the role of PPARγ in more detail as well as the 
ligands responsible for inducing the activation of the PPARs. In addition, future work 
can focus on the effector mechanisms induced by IL-17A that lead to the final 
elimination of the parasite from the host intestine.  
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Samenvatting 
 
De protozoaire parasiet Giardia duodenalis is een globaal sterk aanwezige parasiet 
met een grote waaier aan gastheren. Wanneer Giardia opgenomen wordt door een 
dergelijke gastheer, kan het gastro-intestinale symptomen veroorzaken (zoals diarree, 
misselijkheid en abdominale krampen) en de oorzaak zijn van significante 
productieverliezen in dieren zoals vee. Hoewel infecties regelmatig onopgemerkt en 
snel voorbijgaan zal in een aantal patiënten giardiosis een chronische en persistente 
ziekte zijn. In vee echter is chroniciteit zichtbaar bij elke infectie en kunnen cyst 
excreties nog waargenomen worden in de faeces na 100 dagen. Hoewel er reeds enige 
informatie beschikbaar is omtrent de immuun respons in deze dieren en andere 
natuurlijke gastheren, is de reden achter de waargenomen chroniciteit nog onbekend 
en zijn de Giardia geïnduceerde gastheer-parasiet interacties nog onvoldoende 
gedefinieerd.  
 
Het doel van deze thesis was dan ook het verder ontrafelen van de intestinale immune 
response in vee en om de bekomen resultaten te vergelijken met G. muris  
geïnfecteerde muizen in dewelke infecties van korte duur zijn. Op deze manier 
hebben wij getracht om de oorsprong van de verschillen in infectieduur te 
identificeren.  
 
De eerste stap in het onderzoek dat voorgesteld wordt in deze thesis (hoofdstuk 2) was 
het bestuderen van de intestinale respons in G. duodenalis geïnfecteerde kalveren met 
behulp van een boviene hoge densiteit oligo microarray waardoor de globale 
genexpressie in de dunne darm kon worden nagegaan. De bekomen microarray date 
suggereerde het ontbreken van inflammatie, immune response en immuun cel 
migratie in de geïnfecteerde dieren. Deze bevindingen werden in meer detail 
bestudeerd met behulp van histologische analyses gecombineerd met een 
kwantitatieve real-time PCR op een panel van cytokines. De transcriptie niveaus van 
IL-6, IL-8, IL-13, IL-17 en IFN-γ vertoonde een trend van neerregulatie in het 
jejunum van geïnfecteerde dieren in vergelijking met negatieve controles. Er werd 
geen rekrutering van immuun cellen gezien terwijl ook intestinale pathologische 
letsels, zoals het verkorten van villi of het verhogen van het aantal apoptotische 
cellen, afwezig bleven. Mogelijke regulatoren van deze intestinale response zijn de 
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peroxisoom proliferator-geactiveerde receptoren alfa (PPARα) en gamma (PPARγ), 
voor dewelke een op-gereguleerde expressie kon gezien worden op zowel de 
microarray data als de qRT-PCR analyses.  
 
In hoofdstuk 3 werd een muis model gebruikt waarbij BALB/c en C57Bl/6 muizen 
geïnfecteerd werden met G. muris teneinde een beter inzicht te krijgen in de 
intestinale gastheer respons. Hierbij werd opnieuw qRT-PCR gebruikt om cytokine 
transcriptiepatronen te analyseren in het darmweefsel op verschillende tijdstippen 
tijdens de infectie. In alle muizen kon een sterke op-regulatie van il17a waargenomen 
worden vanaf ongeveer 1 week na infectie. Het belang van IL-17A in de bescherming 
tegen G. muris werd ontegensprekelijk aangetoond in een infectieproef met IL-17 
receptor A C57Bl/6 KO muizen: terwijl in wildtype C57Bl/6 muizen cyst excretie 
sterk daalde na 3 weken infectie, waren de KO muizen niet in staat om zich te 
ontdoen van parasiet. 
 
Hoofdstuk 4 had als doelstelling het onderzoeken van de expressie van de peroxisome 
proliferator-geactiveerde receptoren in G. muris geïnfecteerde muizen aangezien in 
hoofdstuk 2 de op-regulatie van de PPARs in Giardia geïnfecteerde kalveren werd 
waargenomen. Er kon geen op-regulatie waargenomen worden van PPARγ, noch in 
BALB/c noch in C57Bl/ 6 muizen. In de C57BL/6 muizen werd een PPARα inductie 
aangetoond kort na het eerste contact met de parasiet, zowel door de transcriptionele 
op-regulatie van PPARα zelf als van verscheidene downstream target genen zoals Pltp 
en Cpt1. In het algemeen lijkt PPARα geen invloed uit te oefenen op de 
immuunrespons tegen G. muris vermits in BALB/c muizen die een agonist toegediend 
krijgen en in PPARα KO dieren nog steeds een Il17a op-regulatie waargenomen kon 
worden en de dieren geen probleem bleken te hebben met het elimineren van de 
parasiet.  
 
Uit deze thesis kan geconcludeerd worden dat IL-17A waarschijnlijk een belangrijke 
cytokine is in de respons tegen een Giardia infectie en de uiteindelijke eliminatie van 
de parasiet. Bij runderen leken de PPARs verantwoordelijk voor het ontbreken van de 
immuunrespons gezien hun anti-inflammatoire en immuun onderdrukkende 
eigenschappen, maar dit kon niet verder geruggesteund worden in G. muris 
geïnfecteerde muizen. Hoewel PPARα transcriptie op-gereguleerd na contact met de 
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parasiet, leek dit niet de duur van een infectie te beïnvloeden. Een interessante 
invalshoek voor verder toekomstig Giardia gericht onderzoek is het in meer detail 
bestuderen van PPARy alsook van de verantwoordelijke liganden ter inductie en 
activering van de PPAR's. Bovendien kan verder onderzoek ook richten tot het 
ontrafelen van de door IL-17A geïnduceerde effectormechanismen die leiden tot de 
uiteindelijke verwijdering van de parasiet uit de dunne darm van de gastheer. 
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Primer sequences: cattle 
 
Gene symbol Accesion number Primer sequence 
Housekeeping genes   
ACTB NM_173979.3 F: GACATCCGCAAGGACCTCTA 
  
R: ACATCTGCTGGAAGGTGGAC 
GAPDH NM_001034034.1 F: ACCCAGAAGACTGTGGATGG 
  R: CAACAGACACGTTGGGAGTG 
HPRT1 NM_001034035.1 F: CACTGGGAAGACAATGCAGA 
  R: ACACTTCGAGGGGTCCTTTT 
RPLP0 NM_001012682.1 F: CTTCATTGTGGGAGCAGACA 
  R: GGCAACAGTTTCTCCAGAGC 
SDHA NM_174178.2 F: ACATGCAGAAGTCGATGCAG 
  R: GGTCTCCACCAGGTCAGTGT 
UBE2D2 NM_001046496.1 F: AGCCAGTTCTCCAGGCATAA 
  R: TCTTCCCCATCCAAGAACAC 
Validation microarray   
ABCG8 NM_001024663 F: GACCAGCATTGACAGACGAA 
  R: CACTCTGCTCCCTTGACTCC 
ADA NM_173887.2 F: GACCTGGCTGGAGATGAGAC 
  R: CTCGGTCTTGAGTGTGTCCA 
FASN NM_001012669.1 F:CTGAGTCGGAGAACCTGGAG 
  R: CATATTGTGTGCCTGCTTGG 
PPARA NM_001034036.1 F:TCCCTCTTTGTGGCTGCTAT 
  R: TCGTCAGGATGGTTGTTCTG 
PPARG NM_181024.2 F: GATCTTGACGGGAAAGACGA 
  R: ACTGACACCCCTGGAAGATG 
RASGRP2 NM_001099946.1 F: AGCCTGCTGATGGTGTCTTT  
  R: GTTGGCGAGGACTTAGAACG 
RHOD NM_001192338.2 F: ATGTCACCAGTCCACACAGC 
  R: TCACCAGCATCTTGTCCTTG 
Cytokines    
IFN-γ NM_174086.1 F: TTCTTGAATGGCAGCTCTGA 
  R: TTCTCTTCGGCTTTCTGAGG 
IL-1β NM_174093.1 F: AAGGCTCTCCACCTCCTCTC 
  R: TTTGGGGTCTACTTCCTCCA 
IL4 NM_173921.2 F: GCGGACTTGACAGGAATCTC 
  R: TCAGCGTACTTGTGCTCGTC 
IL-6 NM_173923.2 F:  TCCTTGCTGCTTTCACACTC 
  R: CACCCCAGGCAGACTACTTC 
IL-8 NM_173925.2 F: GTTGCTCTCTTGGCAGCTTT 
  R: GGTGGAAAGGTGTGGAATGT 
IL-10 NM_174088.1 F: TGTTGACCCAGTCTCTGCTG 
  R: GGCATCACCTCTTCCAGGTA 
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Gene symbol Accesion number Primer sequence 
IL-13 NM_174090.1 F: GGTGGCCTCACCTCCCCAAG 
  
R: ATGACACTGCAGTTGGAGATGCTG 
IL-17 NM_001008412.1 F: GGACTCTCCACCGCAATGAG 
  R: TGGCCTCCCAGATCACAGA 
TGF-β1 NM_001166068.1 F: CTGCTGTGTTCGTCAGCTCT 
  R: TCCAGGCTCCAGATGTAAGG 
TNF-α NM_173966.2 F: GCCCTCTGGTTCAGACACTC 
  R: AGATGAGGTAAAGCCCGTCA 
 
 
Primer sequences: mice 
 
 
Gene symbol Accession number Primer sequence 
Housekeeping genes (1)  
Actb NM_007393.3 F: CTTCTTTGCAGCTCCTTCGTT 
  R: TTCTGACCCATTCCCACCA 
 
Gadph NM_008084.2 F: CCTCGTCCCGTAGACAAAATG 
  R: TGAAGGGGTCGTTGATGGC 
  
Gusb NM_010368.1 F: CCGATTATCCAGAGCGAGTATG 
  R: CTCAGCGGTGACTGGTTCG 
 
Hprt1 NM_013556.2 F: TGGATACAGGCCAGACTTTGTT 
  RCAGATTCAACTTGCGCTCATC 
 
Rplp0 NM_007475.5 F: ACTGAGATTCGGGATATGCTGT 
  RTGCCTCTGGAGATTTTCGTG 
 
Tbp NM_013684.3 F: CAAACCCAGAATTGTTCTCCTT 
  R:ATGTGGTCTTCCTGAATCCCT 
qRT-PCR   
Camp NM_009921.2 F: TCCCAAGTCTGTGAGGTTCC 
  R: AGGCACATTGCTCAGGTAGC 
 
Cpt1c NM_153679.2 F: TCTTCACTGAGTTCCGATGGG 
  R: ACGCCAGAGATGCCTTTTCC 
 
Defb2 NM_010030.1 F: CCACACCAATGGAGGGTACT 
  R: GGGGTTCTTCTCTGGGAAA 
Defb3 NM_013756.2 F:ATTTCTCCTGGTGCTGCTGT 
  R: TCCACAACTGCCAATCTGAC 
Ifng NM_008337.3 F: AGCTGCCATCGGCTGACCTA 
  R: CCGCAGGAGGAGAAGCCCAGA 
Il1b NM_008361.3 
F: GAAGAGCCCATCCTCTGTGA 
  R: TCCATTGAGGTGGAGAGCTT 
 
Il4 NM_021283.2 
F: TGTACCAGGAGCCATATCCAC 
  R: CACCTTGGAAGCCCTACAGA  
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Gene symbol Accession number Primer sequence 
 
Il13 
 
NM_008355.3 
 
F: CTCAGCCTGCACTGCCTGCC 
  R: GCTCAAGCTGCTGCCTGCCT 
Il17a NM_010552.3 F: CTACCTCAACCGTTCCACGT 
  R: AGCTCTCAGGCTCCCTCTTC 
Il17e NM_080729.3 F: CAGTCCCAGTGACGCTAGAC 
   R: ACCCACTAGAGCGGTGAGAG 
Il17f NM_145856.2 F: TGCTACTGTTGATGTTGGGAC 
  R: AATGCCCTGGTTTTGGTTGAA 
Pdk4 NM_013743.2 F: AGGGAGGTCGAGCTGTTCTC 
  R: GGAGTGTTCACTAAGCGGTCA 
 
Pltp NM_011125.2 F:TGCTGAACATCTCCAACGCAT 
  R: CACTTTAATCCGACCACTGGAAT 
 
Ppara NM_001113418.1 F:GCTGAAGCTGGTGTACGACA  
  R:TGCCCAGAGATTTGAGGTCT 
  
Pparg NM_001127330.1 F:CACCAACTTCGGAATCAGCT  
  R:AACCATTGGGTCAGCTCTTG 
  
Reg3g NM_011260.1 F:GCCCTCAGGACATCTTGTGT 
  R: ACTCCCATCCACCTCTGTTG 
 
Rorc NM_011281.2 F:GAACCAGAACAGGGTCCAGA  
  R:CGTAGAAGGTCCTCCAGTCG 
  
S100a8 NM_013650.2 F:TCACCATGCCCTCTACAAGA 
  R:GAGATGCCACACCCACTTTT 
 
S100a9 NM_001281852.1 F:ACACCCTGAGCAAGAAGGAA 
  R:GTCCAGGTCCTCCATGATGT  
 
Tgfb1 NM_011577.1 F:TTGCTTCAGCTCCACAGAGA 
  R:TGGTTGTAGAGGGCAAGGAC 
 
Tnf NM_001278601.1 F:ACGGCATGGATCTCAAAGAC 
  R:GTGGGTGAGGAGCACGTAGT 
1. Wang, F., J. Wang, D. Liu, and Y. Su. 2010. Normalizing genes for real-
time polymerase chain reaction in epithelial and nonepithelial cells of mouse 
small intestine. Anal Biochem 399:211-217. 
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Manuela, you were there at the very beginning of my PhD. Don’t 
underestimate how much you gave me a push in the right direction.  
Aan al mijn geweldige (ex)collega’s: jullie zijn met teveel om op te noemen, maar ik 
ben echt iedereen dankbaar voor het leuke gezelschap en de hulp. Magda, bedankt om 
mij te helpen met al de muizen. Dirk, Mieke en Isabel, merci voor de hulp met allerlei 
praktische en administratieve zaken.  
Stijn, jij moet een speciale vermelding krijgen. Jij bent één van de leukste 
mensen die ik ken en een enorm behulpzame collega.  
Dries, Frederik and Tao: thanks for the fun moments, in Belgium and China. 
Iris, merci dat ik zoveel met je heb kunnen babbelen over al dan niet werk 
gerelateerde zaken. Marijke, ben blij dat ik je mijn bureaugenote mag noemen. Sien 
(creatief genie) en Fiona: jullie zijn allebei toffe collega’s waarmee ik graag aan de 
keukentafel rondhang. Ana, I’ve enjoyed that I could have the type of conversations 
with you after work that would make other people blush ;). Marvel has a movie plan 
that will ensure releases for several years to come…I’m sure many of these we will 
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watch together! Elise, mijn sushi-sister, altijd paraat “when shit hits the fan”. Kan ik 
je verleiden om mee te gaan naar hierboven vermelde films als ik wasabi-popcorn 
meeneem? Oonagh, ik heb er het volste vertrouwen in dat jij nog mooi onderzoek gaat 
doen op Giardia. Bruno en Johannes, jullie kunnen nog wel jullie mannetje staan 
tegenover dat vrouwelijk geweld, niet?  
Nathalie en Charlotte, ik beschouw jullie al lang niet meer als mijn collega’s. 
Op de eerste plaats en meest van al zijn jullie mijn vriendinnen. We hebben zoveel 
leuke avonden doorgebracht, laten we die traditie gewoon voortzetten, ok? ;) 
Rika, Veronique, Dominique en Melanie, de meisjes van onderzoek, wanneer 
plannen we ons volgende etentje? Bedankt ook aan mijn “oudste” vriendinnen, de 
meisjes uit Limburg, voor de vele verjaardagsfeestjes. En Elke en Kathleen, merci om 
helemaal tot hier af te komen! 
Mijn broer Johnny, merci om er bij te zijn! You’re the best, brotherman! Niet 
stoppen met je zus te voorzien van leuke muziek! She needs it!  
Bedankt ook aan mijn grootouders, Jean en Bertha, die regelmatig vanuit het 
verre Limburg naar Gent kwamen, en daarbij vaak in een treinpanne of file beland 
zijn. Bomma, bedankt voor de soepjes, de keutelkeskoek en het zo vaak “onder 
handen nemen” van mijn vuil appartement (ook al had ik het stiekem-naar mijn 
normen toch-al “mooi” gepoetst). Bompa, merci om altijd je best te doen om te 
luisteren naar mijn te snel geratel of toch minstens te doen alsof.  
 
Herb, je weet wat je voor mij betekent he.  
 
Mijn allerliefste ouders, papa en mama. Hoe kan ik hier nu voldoende 
beschrijven hoe dankbaar ik jullie ben? Hoe ik echt wel “the world’s greatest parents” 
heb? Altijd mijn grootste fans, hoewel jullie vaak vanop de eerste rij meegemaakt 
hebben hoe ik soms een beetje schrik kon hebben van het leven en onzeker was over 
mijn capaciteiten. Maar dit lieten jullie nooit toe en jullie gingen er tegenin met 
aanmoedigingen en een blind vertrouwen in mijn kunnen. En ik heb geen schrik meer. 
Waarom zou ik ook? I can be fearless want ik heb jullie. Gelukkige dertigste 
huwelijksverjaardag! 
 
Leentje 
 
 	  	  
	   	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
